var title_f36_36_37440="Scedosporium cultures";
var content_f36_36_37440=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F52899&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F52899&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scedosporium apiospermum and S. prolificans cultures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 234px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Macroscopic appearance of S. apiospermum (left) and S. prolificans (right).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Barbara D. Alexander, MD, MHS and Sylvia F. Costa, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_36_37440=[""].join("\n");
var outline_f36_36_37440=null;
var title_f36_36_37441="Monkeypox lesions";
var content_f36_36_37441=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F79666&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F79666&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Father, 6/05/03",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 339px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Marshfield Clinic. Copyright &copy; 2005 Marshfield Clinic.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_36_37441=[""].join("\n");
var outline_f36_36_37441=null;
var title_f36_36_37442="Contents: Neonatology";
var content_f36_36_37442=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?17/55/18302\">",
"       Pediatrics",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Neonatology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Neonatology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Antenatal drug exposure",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/4/28746\">",
"           Infants of mothers with substance abuse",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/29/11736\">",
"           Infants with antenatal exposure to serotonin reuptake inhibitors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/57/39833\">",
"           Neonatal opioid withdrawal (Neonatal abstinence syndrome)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cardiac disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/56/20359\">",
"           Cardiac causes of cyanosis in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/2/43048\">",
"           Diagnosis and initial management of cyanotic heart disease in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/62/1002\">",
"           Management of patent ductus arteriosus in premature infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/57/24474\">",
"           Neonatal lupus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/50/15145\">",
"           Pathophysiology, clinical manifestations, and diagnosis of patent ductus arteriosus in premature infants",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Congenital anomalies",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/62/11237\">",
"           Anencephaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/18/8487\">",
"           Craniosynostosis syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/34/44581\">",
"           Facial clefts and holoprosencephaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/13/7386\">",
"           Genetic and environmental causes of birth defects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/21/6488\">",
"           Obstetrical and neonatal management of body stalk anomalies and cloacal abnormalities",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/35/38454\">",
"           Obstetrical management of omphalocele",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/37/10841\">",
"           Overview of craniosynostosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/62/33767\">",
"           Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/57/3991\">",
"           Primary (congenital) encephalocele",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/15/250\">",
"           Syndromes with craniofacial abnormalities",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Congenital malformations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/62/11237\">",
"           Anencephaly",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/29/7639\">",
"           Lower extremity positional deformations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/62/33767\">",
"           Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/57/3991\">",
"           Primary (congenital) encephalocele",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Dermatologic disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/13/22745\">",
"           Benign skin and scalp lesions in the newborn and young infant",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/43/6840\">",
"           Skin nodules in newborns and infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/21/30038\">",
"           Vascular lesions in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/31/15864\">",
"           Vesiculobullous and pustular lesions in the newborn",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Endocrine disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/39/2682\">",
"           Clinical features and detection of congenital hypothyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/6/97\">",
"           Evaluation and management of neonatal Graves' disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/59/24506\">",
"           Evaluation of the infant with ambiguous genitalia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/48/44809\">",
"           Infant of a diabetic mother",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/47/35577\">",
"           Management of the infant with ambiguous genitalia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/59/37816\">",
"           Neonatal hyperglycemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/23/26999\">",
"           Neonatal hypocalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/16/17673\">",
"           Neonatal hypoglycemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/47/40696\">",
"           Thyroid physiology and screening in preterm infants",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastrointestinal disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/39/41591\">",
"           Clinical features and diagnosis of necrotizing enterocolitis in newborns",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/8/34950\">",
"           Emergency complications of Hirschsprung disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/6/23657\">",
"           Gastroesophageal reflux in premature infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/55/31608\">",
"           Intestinal atresia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/5/35928\">",
"           Management of necrotizing enterocolitis in newborns",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/15/41205\">",
"           Overview of the development of the gastrointestinal tract",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/28/28105\">",
"           Pathology and pathogenesis of necrotizing enterocolitis in newborns",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/2/7207\">",
"           Prevention of necrotizing enterocolitis in newborns",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/31/32247\">",
"           Spontaneous intestinal perforation of the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/4/21576\">",
"           Sucking and swallowing disorders in the newborn",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hematologic disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/19/20792\">",
"           Anemia of prematurity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/54/42856\">",
"           Diagnosis of sickle cell syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/52/3912\">",
"           Hemolytic disease of the newborn: RBC alloantibodies in pregnancy and associated serologic issues",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/40/14986\">",
"           Management of thrombosis in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/6/36968\">",
"           Neonatal polycythemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/9/14490\">",
"           Neonatal thrombocytopenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/16/14600\">",
"           Pathogenesis, clinical features, and diagnosis of thrombosis in the newborn",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hyperbilirubinemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/60/24519\">",
"           Approach to neonatal cholestasis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/18/27943\">",
"           Bilirubin metabolism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/50/16169\">",
"           Causes of neonatal cholestasis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/63/25593\">",
"           Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/39/11898\">",
"           Evaluation of unconjugated hyperbilirubinemia in term and late preterm infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/60/19400\">",
"           Hyperbilirubinemia in the premature infant (less than 35 weeks gestation)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/3/39992\">",
"           Pathogenesis and etiology of unconjugated hyperbilirubinemia in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/45/16083\">",
"           Patient information: Jaundice in newborn infants (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/59/21434\">",
"           Treatment of unconjugated hyperbilirubinemia in term and late preterm infants",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Inborn errors of metabolism",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/26/27047\">",
"           Inborn errors of metabolism: Classification",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/58/24489\">",
"           Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/55/13177\">",
"           Inborn errors of metabolism: Identifying the specific disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/0/10250\">",
"           Inborn errors of metabolism: Metabolic emergencies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/16/17673\">",
"           Neonatal hypoglycemia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/30/24037\">",
"           Antiretroviral medications in pregnancy: Entry and integrase inhibitors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/60/16328\">",
"           Antiretroviral medications in pregnancy: Non-nucleoside reverse transcriptase inhibitors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/53/42841\">",
"           Antiretroviral medications in pregnancy: Nucleoside reverse transcriptase inhibitors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/24/18825\">",
"           Antiretroviral medications in pregnancy: Protease inhibitors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/21/27992\">",
"           Chlamydia trachomatis infections in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/47/7928\">",
"           Clinical features and diagnosis of bacterial meningitis in the neonate",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/16/6410\">",
"           Clinical features and diagnosis of sepsis in term and late preterm infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/62/31720\">",
"           Clinical manifestations and diagnosis of Candida infection in neonates",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/49/10010\">",
"           Congenital rubella syndrome: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/63/36855\">",
"           Congenital rubella syndrome: Management, outcome, and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/17/28951\">",
"           Definition and etiology of fever in neonates and infants (less than three months of age)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/30/24039\">",
"           Epidemiology and risk factors for Candida infection in neonates",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/0/31749\">",
"           Epidemiology of pediatric HIV infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/26/28074\">",
"           Evaluation and management of fever in the neonate and young infant (less than three months of age)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/34/39462\">",
"           Gonococcal infection in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/16/18698\">",
"           Group B streptococcal infection in neonates and young infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/63/37881\">",
"           Hepatitis viruses and the newborn: Clinical manifestations and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/3/3130\">",
"           Natural history and classification of pediatric HIV infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/31/35321\">",
"           Neonatal herpes simplex virus infection: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/48/40713\">",
"           Neonatal herpes simplex virus infection: Management and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/0/21512\">",
"           Neonatal pneumonia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/4/13384\">",
"           Non-antiretroviral interventions to reduce perinatal HIV transmission in the developing world",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/43/10936\">",
"           Nosocomial viral infections in the neonate",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/24/28041\">",
"           Overview of TORCH infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/29/40408\">",
"           Parvovirus B19 infection during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/48/9991\">",
"           Prevention of Candida infection in neonates",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/38/40550\">",
"           Strategies for the evaluation of fever in neonates and infants (less than three months of age)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/47/16121\">",
"           Treatment and outcome of bacterial meningitis in the neonate",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/37/26200\">",
"           Treatment and outcome of sepsis in term and late preterm infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/51/40760\">",
"           Treatment of Candida infection in neonates",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/12/29896\">",
"           Unusual fungal infections in the neonate",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/59/14264\">",
"           Urinary tract infections in newborns",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/11/4278\">",
"           Varicella-zoster infection in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/19/26936\">",
"           Vertical transmission of hepatitis C virus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neonatal assessment",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/7/31863\">",
"           Assessment of neonatal pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/21/24922\">",
"           Assessment of the newborn infant",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/30/27113\">",
"           Clinical features and diagnosis of developmental dysplasia of the hip",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/11/14520\">",
"           Incidence and mortality of the premature infant",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/4/28746\">",
"           Infants of mothers with substance abuse",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/21/20823\">",
"           Large for gestational age newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/11/22713\">",
"           Late preterm infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/1/27672\">",
"           Limit of viability",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/31/13814\">",
"           Long-term complications of the premature infant",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/6/34922\">",
"           Long-term neurodevelopmental outcome of premature infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/23/35188\">",
"           Metabolic emergencies at birth",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/60/27594\">",
"           Neonatal outcome, complications, and management of multiple births",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/10/14505\">",
"           Neurological examination of the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/23/10616\">",
"           Overview of causes of and risk factors for fetal growth restriction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/38/21096\">",
"           Perinatal mortality",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/19/8502\">",
"           Physiologic transition from intrauterine to extrauterine life",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/35/22068\">",
"           Postnatal assessment of gestational age",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/26/31142\">",
"           Postterm infant",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/57/5016\">",
"           Primary infantile glaucoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/15/31992\">",
"           Short-term complications of the premature infant",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/23/9593\">",
"           Small for gestational age infant",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neonatal care",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/29/11738\">",
"           Care of the neonatal intensive care unit graduate",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/47/41721\">",
"           Care of the umbilicus and management of umbilical disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/7/27765\">",
"           Discharge planning for high-risk newborns",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/2/39975\">",
"           Etiology, clinical manifestations, and evaluation of neonatal shock",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/60/27591\">",
"           Fluid and electrolyte therapy in newborns",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/22/23912\">",
"           Growth management in preterm infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/47/22265\">",
"           Neonatal birth injuries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/57/39833\">",
"           Neonatal opioid withdrawal (Neonatal abstinence syndrome)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/16/36105\">",
"           Overview of the routine management of the healthy newborn infant",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/9/10393\">",
"           Postnatal care of hydrops fetalis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/18/35114\">",
"           Prevention and treatment of neonatal pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/53/9048\">",
"           Red blood cell transfusions in the newborn",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neonatal procedures",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/46/41705\">",
"           Neonatal circumcision: Risks and benefits",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/57/15256\">",
"           Techniques for neonatal circumcision",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neonatal resuscitation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/46/26346\">",
"           Neonatal resuscitation in the delivery room",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/6/17513\">",
"           Overview of cyanosis in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/61/29656\">",
"           Oxygen monitoring and therapy in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/59/29623\">",
"           Systemic effects of perinatal asphyxia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neonatal screening",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/2/2088\">",
"           Newborn screening",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/13/27865\">",
"           Screening the newborn for hearing loss",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neurologic disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/13/34004\">",
"           Approach to the infant with hypotonia and weakness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/11/6328\">",
"           Clinical features and electrodiagnosis of neonatal seizures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/33/29209\">",
"           Clinical features of cerebral palsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/24/2442\">",
"           Clinical features, diagnosis, and treatment of neonatal encephalopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/44/42697\">",
"           Clinical manifestations and diagnosis of intraventricular hemorrhage in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/6/13417\">",
"           Congenital myopathies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/0/4104\">",
"           Diagnosis and classification of cerebral palsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/50/41768\">",
"           Epidemiology and etiology of cerebral palsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/15/1273\">",
"           Etiology and pathogenesis of infantile spasms",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/14/30953\">",
"           Etiology and pathogenesis of neonatal encephalopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/23/41335\">",
"           Etiology and prognosis of neonatal seizures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/54/5994\">",
"           Hydrocephalus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/46/31465\">",
"           Management and complications of intraventricular hemorrhage in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/37/15962\">",
"           Management and prognosis of cerebral palsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/60/35783\">",
"           Neonatal epileptic syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/10/166\">",
"           Neuromuscular junction disorders in newborns and infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/48/11015\">",
"           Overview of peripheral nerve and muscle disorders causing hypotonia in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/7/33913\">",
"           Periventricular leukomalacia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/2/27690\">",
"           Stroke in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/0/13\">",
"           Treatment of neonatal seizures",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Nutrition",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/8/19593\">",
"           Approach to enteral nutrition in the premature infant",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/21/13657\">",
"           Breast milk expression for the preterm infant",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/12/36040\">",
"           Breastfeeding the preterm infant",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/39/42616\">",
"           Breastfeeding: Parental education and support",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/39/40567\">",
"           Calcium and phosphorus requirements of newborn infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/15/17658\">",
"           Common problems of breastfeeding and weaning",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/6/23655\">",
"           Human milk feeding and fortification of human milk for premature infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/47/32505\">",
"           Infant benefits of breastfeeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/1/8217\">",
"           Initiation of breastfeeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/27/1461\">",
"           Maternal and economic benefits of breastfeeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/53/43864\">",
"           Maternal nutrition during lactation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/28/458\">",
"           Nutritional composition of human milk and preterm formula for the premature infant",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/36/6727\">",
"           Nutritional composition of human milk for full-term infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/50/27434\">",
"           Parenteral nutrition in premature infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/23/6519\">",
"           Physiology of lactation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/1/32794\">",
"           Principles of medication use during lactation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/61/39896\">",
"           n-3 Long chain polyunsaturated fatty acids (LCPUFA) for preterm and term infants",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Ophthalmologic disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/32/10762\">",
"           Retinopathy of prematurity",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Renal and urological disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/30/27114\">",
"           Acute kidney injury (acute renal failure) in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/24/24966\">",
"           Clinical manifestations and initial management of infants with bladder exstrophy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/36/7753\">",
"           Congenital and infantile nephrotic syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/60/37833\">",
"           Etiology, clinical features, and diagnosis of neonatal hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/59/42936\">",
"           Management of hypertension in infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/47/26356\">",
"           Nephrocalcinosis in neonates",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/52/42824\">",
"           Overview of antenatal hydronephrosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/20/34119\">",
"           Postnatal management of antenatal hydronephrosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/58/16296\">",
"           Prenatal diagnosis of renal agenesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/23/44407\">",
"           Prune-belly syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Respiratory disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/29/29144\">",
"           Bronchopulmonary sequestration",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/16/21768\">",
"           Clinical features and diagnosis of meconium aspiration syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/23/28026\">",
"           Congenital diaphragmatic hernia in the neonate",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/11/44214\">",
"           Congenital lobar emphysema",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/50/810\">",
"           Congenital pulmonary airway (cystic adenomatoid) malformation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/5/36951\">",
"           Diaphragmatic paralysis in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/14/43235\">",
"           Eventration of the diaphragm in infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/13/43223\">",
"           Management of apnea of prematurity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/24/15753\">",
"           Management of bronchopulmonary dysplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/39/4729\">",
"           Mechanical ventilation in neonates",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/51/25398\">",
"           Outcome of infants with bronchopulmonary dysplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/49/31511\">",
"           Overview of neonatal respiratory distress: Disorders of transition",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/22/18793\">",
"           Pathogenesis and clinical features of bronchopulmonary dysplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/4/12360\">",
"           Pathogenesis, clinical presentation, and diagnosis of apnea of prematurity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/12/19656\">",
"           Pathophysiology and clinical manifestations of respiratory distress syndrome in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/37/27225\">",
"           Persistent pulmonary hypertension of the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/17/3353\">",
"           Postnatal use of glucocorticoids in bronchopulmonary dysplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/13/18648\">",
"           Prevention and management of meconium aspiration syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/34/43561\">",
"           Prevention and treatment of respiratory distress syndrome in preterm infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/14/27880\">",
"           Prevention of bronchopulmonary dysplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/33/4631\">",
"           Pulmonary air leak in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/40/17034\">",
"           Pulmonary outcomes of bronchopulmonary dysplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/2/32804\">",
"           Transient tachypnea of the newborn",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Systemic disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/57/24474\">",
"           Neonatal lupus",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-95900C6882-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f36_36_37442=[""].join("\n");
var outline_f36_36_37442=null;
var title_f36_36_37443="Gentamicin (ophthalmic): Pediatric drug information";
var content_f36_36_37443=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Gentamicin (ophthalmic): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?3/21/3412?source=see_link\">",
"    see \"Gentamicin (ophthalmic): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/23/28020?source=see_link\">",
"    see \"Gentamicin (ophthalmic): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8107111\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Garamycin&reg;;",
"     </li>",
"     <li>",
"      Gentak&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8107112\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Diogent&reg;;",
"     </li>",
"     <li>",
"      Garamycin&reg;;",
"     </li>",
"     <li>",
"      Garasone;",
"     </li>",
"     <li>",
"      Gentak&reg;;",
"     </li>",
"     <li>",
"      Gentocin;",
"     </li>",
"     <li>",
"      PMS-Gentamicin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F10495046\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Aminoglycoside",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Ophthalmic",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F12674626\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Ophthalmic infections:",
"     </b>",
"     Ophthalmic:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ointment: Apply 2-3 times daily;",
"     <b>",
"      Note:",
"     </b>",
"     Use should be reserved for treatment of susceptible infection and  not  routine prophylaxis for ophthalmia neonatorum.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution: Instill 1-2 drops every 4 hours; up to 2 drops every hour for severe infections",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F10481532\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?3/21/3412?source=see_link\">",
"      see \"Gentamicin (ophthalmic): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Ophthalmic infections:",
"     </b>",
"     Infants, Children, and Adults: Ophthalmic:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ointment: Instill",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     inch (1.25 cm) 2-3 times daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution: Instill 1-2 drops every 4 hours; up to 2 drops every hour for severe infections",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F8107326\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ointment, ophthalmic:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gentak&reg;: 0.3% (3.5 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ointment, ophthalmic [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Garamycin&reg;: 0.3% (3.5 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, ophthalmic [drops]: 0.3% (5 mL, 15 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Garamycin&reg;: 0.3% (5 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gentak&reg;: 0.3% (5 mL) [contains benzalkonium chloride]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F8107123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F10481607\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Gentamicin solution is not for subconjunctival injection. Solution may be instilled into the affected eye or a small amount of ointment may be placed into the conjunctival sac. Avoid contaminating tip of the solution bottle or ointment tube.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution: Apply finger pressure to lacrimal sac during and for 1-2 minutes after instillation to decrease risk of absorption and systemic effects",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F15516368\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ointment: Store at 2&deg;C to 30&deg;C (36&deg;F to 86&deg;F)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution: Store at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); avoid exposure to excessive heat.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F10481528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Topical treatment of ophthalmic infections caused by susceptible bacteria (FDA approved in ages &ge;1 month and adults)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F8107106\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Gentamicin may be confused with gentian violet, kanamycin, vancomycin",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F8107181\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ophthalmic: Burning, irritation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Allergic reaction, corneal ulceration, hallucinations, purpura, thrombocytopenia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10481529\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to gentamicin, any component, or other aminoglycosides",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F15516367\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Solution is not for injection into the eye, including  the anterior chamber of the eye, nor for subconjunctival injection. Topical use has been associated with local sensitization (redness, irritation); discontinue if sensitization is noted. Prolonged use may result in fungal or bacterial superinfection; if purulent discharge, inflammation, or pain are increased, therapy should be reevaluated. Not intended for long-term therapy. Ointment may delay corneal healing. Ointment should not be used for routine prophylaxis for ophthalmia neonatorum due to recent reports of severe ocular reactions described as eyelid erythema and swelling, ocular discharge, and periocular blistering, typically reported within 48 hours after administration (Binenbaum, 2010; Nathawad, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299396\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F8107202\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F9771694\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F8107126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were observed following systemic administration of gentamicin in animal reproduction studies; therefore, gentamicin ophthalmic is classified as pregnancy category C. The amount of gentamicin available systemically following application of the ophthalmic drops is below the limit of detection (&lt;0.5 mcg/mL). Systemic absorption would be required in order for gentamicin to cross the placenta and reach the fetus. When administered I.M. or I.V., gentamicin crosses the placenta. Refer to the Gentamicin (Systemic) monograph for details.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F10481531\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits cellular initiation of bacterial protein synthesis by binding to 30S and 50S ribosomal subunits resulting in a defective bacterial cell membrane",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F15516369\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Absorption: Ophthalmic drops: Systemic absorption: Undetected (&lt;0.5 mcg/mL)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F15516370\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/23/28020?source=see_link\">",
"      see \"Gentamicin (ophthalmic): Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Wash hands before instilling. Do not touch tip of applicator or let tip of applicator touch eye or eyelid. Temporary stinging or blurred vision may occur. Report persistent pain, burning, vision changes, swelling, itching, or worsening of condition.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Binenbaum G, Bruno CJ, Forbes BJ, et al, \"Periocular Ulcerative Dermatitis Associated With Gentamicin Ointment Prophylaxis in Newborns,\"",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 2010, 156(2):320-1.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37443/abstract-text/20105641/pubmed\" id=\"20105641\" target=\"_blank\">",
"        20105641",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bras JF and Coyle-Gilchrist MM, \"Genticin in Conjunctivitis and Keratitis,\"",
"      <i>",
"       Br J Ophthalmol",
"      </i>",
"      , 1968, 52(7):560-1.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37443/abstract-text/5724444/pubmed\" id=\"5724444\" target=\"_blank\">",
"        5724444",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nathawad R, Mendez H, Ahmad A, et al, \"Severe Ocular Reactions After Neonatal Ocular Prophylaxis With Gentamicin Ophthalmic Ointment,\"",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 2011, 30(2):175-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37443/abstract-text/20885334/pubmed\" id=\"20885334\" target=\"_blank\">",
"        20885334",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15996 Version 23.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-C5FDE4D645-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_36_37443=[""].join("\n");
var outline_f36_36_37443=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8107111\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8107112\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10495046\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12674626\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10481532\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8107326\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8107123\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10481607\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15516368\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10481528\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8107106\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8107181\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10481529\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15516367\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299396\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8107202\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9771694\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8107126\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10481531\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15516369\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15516370\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/15996\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/15996|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?3/21/3412?source=related_link\">",
"      Gentamicin (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/23/28020?source=related_link\">",
"      Gentamicin (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?0/47/761?source=related_link\">",
"      Gentamicin (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?18/8/18564?source=related_link\">",
"      Gentamicin (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/63/8185?source=related_link\">",
"      Gentamicin (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?16/46/17123?source=related_link\">",
"      Gentamicin (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?37/59/38835?source=related_link\">",
"      Gentamicin (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?30/20/31042?source=related_link\">",
"      Gentamicin (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_36_37444="Positive skin patch test";
var content_f36_36_37444=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F81086&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F81086&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 503px\">",
"   <div class=\"ttl\">",
"    Positive patch test reactions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 483px; height: 302px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panel A) At a 48-hour reading of abacavir patch test; image is of a patient participating in a large clinical study in which the four patch testing wells contained, in a blinded configuration, (i) abacavir commercial (Ziagen) formulation at 1 percent in white petrolatum, (ii) abacavir commercial (Ziagen) formulation at 10 percent in white petrolatum, (iii) petrolatum control and (iv) Ziagen excipient control; Panel B) close-up showing vesicular reaction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Shear NH, Milpied B, Bruynzeel DP, Phillips EJ. A review of drug patch testing and implications for HIV clinicians. AIDS 2008; 22:999. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_36_37444=[""].join("\n");
var outline_f36_36_37444=null;
var title_f36_36_37445="Morbilliform drug eruption";
var content_f36_36_37445=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F54205%7EALLRG%2F70062&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F54205%7EALLRG%2F70062&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Exanthematous (morbilliform) drug eruption",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Numerous erythematous macules and papules are present in this patient with a morbilliform drug eruption.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Exanthematous (morbilliform) drug eruption",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 236px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Drug-induced exanthems, such as this morbilliform eruption, often begin in dependent areas and generalize.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Andrew Samel, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_36_37445=[""].join("\n");
var outline_f36_36_37445=null;
var title_f36_36_37446="Duplex pulsed doppler sonogram";
var content_f36_36_37446=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F80085&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F80085&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Duplex pulsed Doppler sonogram depicting umbilical arterial circulation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 371px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The left panel shows pulsed Doppler interrogation of the umbilical artery in a two dimensional color Doppler image. The Doppler beam path is indicated by the cursor line and the Doppler sample volume is indicated by two horizontal lines. The right panel shows the spectral Doppler waveforms from the sampled umbilical artery location. Note the prominent end-diastolic flow typical of the last weeks of pregnancy reflecting declining flow impedance. The peak velocity is indicated by the blue margin of the waveform. The vertical lines are defining one cardiac cycle. The Doppler indices are shown in lower left corner.",
"    <div class=\"footnotes\">",
"     %: percent.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Maulik D. Umbilical Doppler velocimetry: normative data and diagnostic efficacy. In Maulik D. (ed) Doppler Ultrasound in Obstetrics and Gynecology; Springer Verlag. Copyright &copy; 2005 Springer Verlag.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_36_37446=[""].join("\n");
var outline_f36_36_37446=null;
var title_f36_36_37447="Progression of hiatal hernia";
var content_f36_36_37447=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F54169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F54169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Progressive anatomic disruption of the gastroesophageal membrane",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 374px; height: 486px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic appearance, looking upward from the gastric cardia toward the hiatus. The normal view is shown, followed by progressively increasing laxity of the phrenoesophageal membrane, leading to gross incompetence (grade IV) and a type I hiatal hernia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Hill LD, Kraemer SJ, Aye RW, et al. Laparoscopic Hill repair. Contemp Surg 1994; 44:13.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_36_37447=[""].join("\n");
var outline_f36_36_37447=null;
var title_f36_36_37448="Botulism";
var content_f36_36_37448=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Botulism",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/36/37448/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/36/37448/contributors\">",
"     P Samuel Pegram, MD, FACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/36/37448/contributors\">",
"     Sean M Stone, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/36/37448/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/36/37448/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/36/37448/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/36/37448/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/36/37448/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Botulism is a rare but potentially life-threatening neuroparalytic syndrome resulting from the action of a neurotoxin elaborated by the bacterium Clostridium botulinum. This disease has a lengthy history; the first investigation of botulism occurred in the 1820s with a case series about hundreds of patients with \"sausage poisoning\" in a southern German town [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/1\">",
"     1",
"    </a>",
"    ]. Several decades later in Belgium, the association was demonstrated between a neuromuscular paralysis and ham infected by a spore-forming bacillus that was isolated from the ham. The organism was named Bacillus botulinus after the Latin word for sausage, botulus.",
"   </p>",
"   <p>",
"    The microbiology, pathogenesis, epidemiology, clinical manifestations, diagnosis, and treatment of botulism will be discussed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11649389\">",
"    <span class=\"h1\">",
"     TYPES OF BOTULISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The modern syndrome of botulism occurs in five forms, differentiated by the mode of acquisition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Foodborne botulism &mdash; Ingestion of food contaminated by preformed botulinum toxin",
"     </li>",
"     <li>",
"      Infant botulism &mdash; The ingestion of clostridial spores that then colonize the host's gastrointestinal (GI) tract and release toxin produced in vivo",
"     </li>",
"     <li>",
"      Wound botulism &mdash; Infection of a wound by Clostridium botulinum with subsequent in vivo production of neurotoxin",
"     </li>",
"     <li>",
"      Adult enteric infectious botulism or adult infectious botulism of unknown source &mdash; Similar to infant botulism in that toxin is produced in vivo in the GI tract of an infected adult host",
"     </li>",
"     <li>",
"      Inhalational botulism &mdash; The form that would occur if aerosolized toxin was released in an act of bioterrorism",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, iatrogenic cases of botulism have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/3\">",
"     3",
"    </a>",
"    ], and botulism has become the subject of speculation as a possible bioterrorism threat. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/46/22247?source=see_link\">",
"     \"Identifying and managing casualties of biological terrorism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;C. botulinum is a heterogeneous group of gram-positive, rod-shaped, spore-forming, obligate anaerobic bacteria. They are ubiquitous and are easily isolated from the surfaces of vegetables, fruits, seafood, and exist in soil and marine sediment worldwide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/4\">",
"     4",
"    </a>",
"    ]. Eight strains of C. botulinum have been distinguished based upon the antigenic specificities of their toxins (a single strain almost always produces only one toxin type).",
"   </p>",
"   <p>",
"    The spores of C. botulinum are heat-resistant, easily surviving 100&ordm;C at one atmosphere for five or more hours. However, spores can be destroyed by heating to 120&ordm;C for five minutes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/5\">",
"     5",
"    </a>",
"    ]. When appropriate environmental conditions are present, the spores will germinate and grow into toxin-producing bacilli. These environmental parameters include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Restricted oxygen exposure (either an anaerobic or semi-anaerobic environment)",
"     </li>",
"     <li>",
"      Low acidity (pH &gt;4.6) water",
"     </li>",
"     <li>",
"      A temperature of 25 to 37&ordm;C for ideal growth; however, some strains may grow in temperatures as low as 4&ordm;C.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some strains (A and B) produce proteolytic enzymes that denature and \"spoil\" the foods they inhabit, leaving them with an unpleasant appearance, taste or smell. Other strains do not overtly change the food, and thus, contamination cannot reliably be suspected on the basis of the look, odor, or taste of the food.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eight distinct C. botulinum toxin types have been described: A, B, C1, C2, D, E, F, and G. Of these eight, types A, B, E, and rarely F and G cause human disease, whereas C and D cause disease in animals such as cattle, ducks, and chickens. Clostridium butyricum and Clostridium barati are two other distinct Clostridia species that are known to have produced botulinum type E and F toxins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/6\">",
"     6",
"    </a>",
"    ]. In contrast to the spores, the toxin is a heat-labile polypeptide readily denatured by heating above 80&ordm;C. The polypeptide toxin is composed of a light and heavy chain with a combined molecular weight of 150 to 165 kDa.",
"   </p>",
"   <p>",
"    Regardless of the route of entry into the body, the toxin disperses widely via the vascular system and binds to a specific receptor (synaptotagmin II) on the presynaptic sides of peripheral cholinergic synapses at ganglia and neuromuscular junctions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. The heavy chain of the toxin binds to the receptors, allowing the light chain to translocate into the nerve cell via receptor mediated-endocytosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    After gaining entrance to the cell's cytoplasm, the toxin produces an irreversible disruption in stimulation-induced acetylcholine release by that presynaptic nerve terminal. Return of synaptic function requires sprouting of a new presynaptic terminal with subsequent formation of a new synapse, a process that requires approximately six months. Adrenergic synapses are not affected by the toxin, nor does the toxin appear to permeate the blood brain barrier, therefore limiting involvement to the peripheral cholinergic nervous system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Botulinum toxin is the most potent bacterial toxin, and perhaps the most potent known poison. The MLD (minimum lethal dose in experimental mice) of botulinum toxin is 0.0003",
"    <span class=\"nowrap\">",
"     mcg/kg.",
"    </span>",
"    By comparison, the MLDs for curare and sodium cyanide are 500 and 10,000",
"    <span class=\"nowrap\">",
"     mcg/kg,",
"    </span>",
"    respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/11\">",
"     11",
"    </a>",
"    ]. It is estimated that one gram of aerosolized botulism toxin could kill at least 1.5 million people [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The toxin itself has no smell or taste. If ingested, the toxin is primarily absorbed by the stomach and small intestine, although the large intestine is capable of absorbing the toxin as well. The toxin is resistant to degradation by gastric acidity and human alimentary enzymes alike. However, botulinum toxin is inactivated in chlorinated water after only 20 minutes of exposure and in fresh water after three to six days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Incidence by mode of acquisition",
"    </span>",
"    &nbsp;&mdash;&nbsp;An average of 110 cases of botulism are reported each year in the United States according to the Centers for Disease Control and Prevention (CDC). Approximately 72 percent of these cases are infant botulism, 25 percent are foodborne botulism, and the remaining 3 percent wound botulism. Adult infectious botulism is only occasionally reported.",
"   </p>",
"   <p>",
"    Infant botulism has been recognized as a separate disease entity since 1976 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/14\">",
"     14",
"    </a>",
"    ]. Since that time, over 900 cases of infant botulism have been reported in the United States, making it the most frequently reported form of botulism in the world [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/15\">",
"     15",
"    </a>",
"    ]. Despite the frequency of infant botulism among all cases of botulism, the CDC notes little change in the number of cases of infant or foodborne botulism in recent years.",
"   </p>",
"   <p>",
"    By contrast, reports of wound botulism have increased dramatically, most noticeably in California. From 1951 through 1987, an average of 0.49 wound botulism cases per year were reported to the California Department of Health Services compared with 2.25 cases per year in 1988 through 1991, three cases in 1992, four in 1993, 11 in 1994, and 23 in 1995 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A new cause, iatrogenic botulism, occurred in four patients who received botulinum toxin injections using an unlicensed, highly concentrated preparation of botulinum toxin A [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/3\">",
"     3",
"    </a>",
"    ]. The patients may have received doses as high as 2857 times the estimated the human lethal dose by injection and had serum toxin levels 21 to 43 times the estimated lethal human dose by injection. After administration of equine serum antitoxin, all patients survived but required prolonged mechanical ventilation and physical rehabilitation. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Antitoxin'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Sources",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Wounds",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vast majority of cases of wound botulism in California since 1988 has involved injection drug users, particularly those using \"black tar\" heroin by the subcutaneous or intramuscular (not intravascular) route [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Recurrent wound botulism has occurred in some injection drug users [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/19\">",
"     19",
"    </a>",
"    ]. How the heroin becomes contaminated with the clostridial organisms or their toxins is unknown.",
"   </p>",
"   <p>",
"    Wound botulism has also been reported in patients who inhale cocaine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/20\">",
"     20",
"    </a>",
"    ]. The patients presented with sinusitis, with one patient growing C. botulinum from a sinus aspirate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Foodborne botulism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Foodborne cases of botulism are most commonly recognized as small outbreaks, usually involving home canned foods such as fruits, vegetables, and fish [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Commercial products and restaurants are occasionally sources [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/22-28\">",
"     22-28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The highest rates of foodborne botulism in the United States occur in Alaska Natives as a result of ingestion of fish and marine mammals that have been aged [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Surveillance data from the United States Centers for Disease Control and Prevention between 1947 and 2007 found a mean annual incidence of 6.9 cases per 100,000 Alaska Native persons compared with an overall rate in the United States of 0.0068 cases per 100,000 persons. Toxin types A, B, and E have all been associated with foodborne botulism, although toxin type E is the most commonly implicated type in foodborne botulism in Alaska [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several foodborne outbreaks have been described, as illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A large outbreak of botulism involving 209 persons occurred in Thailand in March 2006 related to home-canned bamboo shoots [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/31,32\">",
"       31,32",
"      </a>",
"      ]. Ill persons had attended an annual religious rite where food was consumed and home-canned bamboo shoots were the only item eaten by all of the affected persons. C. botulinum was subsequently cultured from leftover bamboo shoots. Of the 209 persons affected, 141 were hospitalized and 42 required mechanical ventilation.",
"     </li>",
"     <li>",
"      Commercial carrot juice was identified as a source of type A botulism that resulted in the hospitalization of six patients in Georgia, Florida and Ontario, Canada, in September 2006 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/24,25\">",
"       24,25",
"      </a>",
"      ]. Improper refrigeration during transport or storage was suspected to be responsible for growth of C. botulinum contaminating the juice, allowing production of botulinum toxin. In addition, no preservatives, salt, or sugars were added to the carrot juice, which may be necessary to prevent the germination of naturally present C. botulinum spores in the event of improper refrigeration.",
"     </li>",
"     <li>",
"      In 2007, an outbreak of botulism caused by sausage affected 66 individuals in China [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/26\">",
"       26",
"      </a>",
"      ]. An outbreak investigation revealed that the sausage had been transported and stored in retail outlets without refrigeration.",
"     </li>",
"     <li>",
"      Five outbreaks of botulism were detected among prison inmates in the United States between 2004 and 2012, affecting between one and eight prisoners per outbreak [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/33\">",
"       33",
"      </a>",
"      ]. Investigations identified pruno, an illicit alcoholic beverage, as the source of the outbreaks. Pruno is typically made by fermenting fruit and sugar in water; other commonly used ingredients include potatoes, corn, bread, and rice. Potatoes were the suspected source of C. botulinum spores in these outbreaks.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Infant botulism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infant botulism has long been associated with the ingestion of raw honey. However, this was most likely a minor environmental reservoir, since widespread education of the public has done little to affect the incidence of infant botulism in the United States.",
"   </p>",
"   <p>",
"    Most cases in the United States are thought to result from ingestion of environmental dust containing C. botulinum spores. The incidence of reported cases is highest in Utah, Pennsylvania, and California, states in which soil botulinum spore counts are high. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/10/166?source=see_link&amp;anchor=H14#H14\">",
"     \"Neuromuscular junction disorders in newborns and infants\", section on 'Infant botulism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Botulism is classically described as the acute onset of bilateral cranial neuropathies associated with symmetric descending weakness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/5\">",
"     5",
"    </a>",
"    ]. The CDC has also suggested that the following be considered as key features of the botulism syndrome:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Absence of fever",
"     </li>",
"     <li>",
"      Symmetric neurologic deficits",
"     </li>",
"     <li>",
"      The patient remains responsive",
"     </li>",
"     <li>",
"      Normal or slow heart rate and normal blood pressure",
"     </li>",
"     <li>",
"      No sensory deficits with the exception of blurred vision",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Nonspecific gastrointestinal symptoms also may be seen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/34,35\">",
"     34,35",
"    </a>",
"    ] and are occasionally the predominant manifestations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Infant botulism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infant botulism results from intestinal colonization by Clostridium botulinum and affects infants between one week and 12 months of age. Most cases occur between two and eight months of age, and the median age of onset is three to four months. The disease presentation and severity are variable, most likely due to variations in the size of the bacterial inoculum and in host susceptibility. The initial presentation may involve constipation, shortly followed by weakness, feeding difficulties, descending or global hypotonia, drooling, anorexia, irritability, and weak cry.",
"   </p>",
"   <p>",
"    A detailed discussion of infant botulism is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/10/166?source=see_link&amp;anchor=H14#H14\">",
"     \"Neuromuscular junction disorders in newborns and infants\", section on 'Infant botulism'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For suspected infant botulism occurring in any state, the California Department of Health Services, Infant Botulism Treatment and Prevention Program should be contacted (",
"    <a class=\"external\" href=\"file://www.infantbotulism.org/\">",
"     www.infantbotulism.org/",
"    </a>",
"    or 510-231-7600).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Foodborne botulism",
"    </span>",
"    &nbsp;&mdash;&nbsp;The onset of symptoms in foodborne botulism usually begins within 12 to 36 hours after ingestion of the preformed toxin, but the incubation period may range from several hours to one week. Prodromal symptoms often include nausea, vomiting, abdominal pain, diarrhea, and dry mouth with sore throat, but these symptoms can occur at any time throughout the course of the illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cranial nerve involvement most commonly marks the onset of symptomatic illness and can include blurred vision (secondary to fixed pupillary dilation and palsies of cranial nerves III, IV, and VI), diplopia, nystagmus, ptosis, dysphagia, dysarthria, and facial weakness. Descending muscle weakness usually progresses to the trunk and upper extremities, followed by the lower extremities. Urinary retention and constipation are common resulting from smooth muscle paralysis. Occasionally paresthesias and asymmetric limb weakness are seen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/37\">",
"     37",
"    </a>",
"    ]. Similar to infant botulism, respiratory difficulties (eg, dyspnea) requiring intubation and mechanical ventilation are common, caused by diaphragmatic paralysis, upper airway compromise, or both. Despite the evidence of neurologic involvement, cerebrospinal fluid analysis is normal.",
"   </p>",
"   <p>",
"    The disease presentation can be quite variable, ranging from mild complaints or to death within the first 24 hours of developing symptoms. A small outbreak of clinically mild botulism resulted from exposure to low doses of botulinum toxin type E from contaminated, home-salted fish [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/35\">",
"     35",
"    </a>",
"    ]. All five patients presented with gastrointestinal symptoms and two had minimal cranial nerve palsies. In other mild cases, ocular cranial nerve involvement is minimal or the sole manifestation of the illness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Wound botulism",
"    </span>",
"    &nbsp;&mdash;&nbsp;In theory, wound botulism should only be associated with puncture wounds, subcutaneous abscesses, and deep space infections, which provide the anaerobic environment required for spores to germinate and the organism to thrive. However, cases have been described involving abrasions, lacerations, open fractures, surgical incisions, and even a closed hematoma without appreciable skin defect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/38\">",
"     38",
"    </a>",
"    ]. A case has been reported of pelvic abscess, paralysis, and toxemia due to C. botulinum following a laparoscopic appendectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Wound botulism differs only slightly from foodborne botulism in presentation. Wound botulism lacks the prodromal GI symptoms common to foodborne botulism and has a longer incubation period of approximately ten days. Patients may also have fever with wound botulism, but this probably results from concurrent bacterial infection of the wound by non-clostridial species.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Adult infectious botulism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with this form of botulism develop enteric colonization with Clostridia and are found to have spores in their feces or in ingested food products. No preformed toxin is identified in any food source. The normal GI tract, except in infants, is resistant to colonization by C. botulinum. The changes in intestinal flora or mucosal defense required to allow this colonization are not known. However, it is thought that achlorhydria, GI diseases, or the post-operative state predispose to colonization. This syndrome resembles infant botulism in its symptoms and course.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis for foodborne, wound, and adult enteric botulism includes: myasthenia gravis, Lambert-Eaton myasthenic syndrome (LEMS), tick paralysis, Guillain-Barr&eacute; syndrome, poliomyelitis, stroke, and heavy metal intoxication. Less likely diagnoses include tetrodotoxin and shellfish poisoning and antimicrobial-associated paralysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The differential diagnosis of infant botulism is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/10/166?source=see_link&amp;anchor=H14#H14\">",
"     \"Neuromuscular junction disorders in newborns and infants\", section on 'Infant botulism'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Myasthenia gravis lacks autonomic symptoms, while these symptoms, especially involving salivation and erectile function, are common in LEMS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/40\">",
"     40",
"    </a>",
"    ]; both entities can be excluded by electromyography (EMG) or antibody study. Tensilon (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/21/35156?source=see_link\">",
"     edrophonium",
"    </a>",
"    ) tests to rule out myasthenia gravis should not be conducted, as they are often falsely positive in patients with botulism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/41\">",
"     41",
"    </a>",
"    ]. Guillain-Barr&eacute; syndrome usually involves ascending paralysis, sensory findings, and elevated cerebrospinal fluid protein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/38\">",
"     38",
"    </a>",
"    ]. A tick check should be performed as part of the physical examination since the ticks transmitting tick paralysis may still be attached when the patient presents. Cerebrospinal fluid (CSF) studies of most patients with meningitis and encephalitis will reveal elevated protein and red and white blood cells. White blood cell counts, CSF studies, and sedimentation rates are all normal in patients with botulism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important issue in the diagnosis of any of the four syndromes of botulism is the initial consideration of the disease. A careful history and physical examination are essential.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Infant botulism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infant botulism is a rare disorder and the diagnosis is often missed. As an example, the diagnosis was suspected on admission in only one-half of infants enrolled in a randomized trial testing the efficacy of botulinum immune globulin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum assays for botulinum toxin are often negative in cases of infant botulism. The diagnosis is supported by the isolation of C. botulinum spores from the stool and is confirmed by the identification of botulinum toxin in stool samples. However, stool sample assays do not yield timely results. Anaerobic cultures often take up to six days for growth and identification of the organism; and initial detection of toxin requires one to four days.",
"   </p>",
"   <p>",
"    The delays with these confirmatory tests are important since therapy should be administered as early as possible. Thus, a presumptive diagnosis should be made based upon the clinical presentation and electrophysiologic findings, while the confirmatory stool studies are pending. These issues are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/10/166?source=see_link&amp;anchor=H14#H14\">",
"     \"Neuromuscular junction disorders in newborns and infants\", section on 'Infant botulism'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For suspected infant botulism occurring in any state, the California Department of Health Services, Infant Botulism Treatment and Prevention Program should be contacted (",
"    <a class=\"external\" href=\"file://www.infantbotulism.org/\">",
"     www.infantbotulism.org/",
"    </a>",
"    or 510-231-7600).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Foodborne botulism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients presenting with clinical signs and symptoms of foodborne botulism should have serum analysis for toxin by bioassay in mice. Demonstration of toxin in the blood is diagnostic. This laboratory test is performed by special laboratories whose locations may be obtained by contacting state epidemiologists or regional offices of the CDC.",
"   </p>",
"   <p>",
"    Analysis of stool, vomitus, and suspected food items may also reveal toxin, which is diagnostic when coupled with the appropriate clinical and neurologic findings. Toxin has been detected from the serum up to 12 days following ingestion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/24,43\">",
"     24,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    EMG studies may be useful in these patients as well, but are not generally required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Wound botulism",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with foodborne and infant botulism, the history and physical examination are key to the diagnosis. The history should include questions about injection drug use and trauma. The only type of botulism to commonly involve fever and leukocytosis is wound botulism. One study found nearly half of the patients examined to have leukocytosis during their clinical course [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Isolation of C. botulinum from the wound site is diagnostic and should be attempted. Stool and vomitus assays for toxin yield nothing in cases of wound botulism and should not be attempted. Serum assays for toxin are frequently negative and therefore rarely helpful. As an example, among a cohort of 73 individuals with injection drug use-associated wound botulism, only 50 (68 percent) had toxin detected from the serum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    EMG is a useful diagnostic tool in wound as well as in infant botulism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Adult enteric",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnosis is based upon the same clinical findings and tests as for infant botulism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any patient with clinical signs, symptoms, or history suspicious for botulism should be hospitalized immediately and meticulously monitored for signs of respiratory failure.",
"   </p>",
"   <p>",
"    A detailed discussion of infant botulism is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/10/166?source=see_link&amp;anchor=H14#H14\">",
"     \"Neuromuscular junction disorders in newborns and infants\", section on 'Infant botulism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monitoring should include pulse oximetry, spirometry, arterial blood gas measurement, and clinical evaluation of ventilation, perfusion, and upper airway integrity. Respiratory failure is the primary cause of death in these patients. Prompt intubation with mechanical ventilation will dramatically decrease the risk of mortality.",
"   </p>",
"   <p>",
"    Intubation should be considered for those patients with inadequate or worsening upper airway competency, and those with a vital capacity less than 30 percent of predicted. Infants and severe adult cases may require prolonged mechanical ventilation. Supportive care in these cases should also include small volume continuous nasogastric feedings (to minimize aspiration risk) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/45\">",
"     45",
"    </a>",
"    ]. When severe ileus is present, parenteral hyperalimentation may be required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Antitoxin",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two botulism antitoxin therapies available in the United States. Equine serum heptavalent botulism antitoxin is used to treat children older than one year of age and adults; human-derived",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/39/12916?source=see_link\">",
"     botulism immune globulin",
"    </a>",
"    is used for infants less than one year of age. A pentavalent antitoxin is available within the Department of Defense but is not available for public use.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Equine serum botulism antitoxin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antitoxin therapy with equine serum heptavalent botulism antitoxin, which contains antibodies to the seven known botulism toxin types (A through G), is available in the United States through State Health Departments or (if after regular business hours) the State Health Department representative on call, who can then obtain antitoxin through the CDC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/46\">",
"     46",
"    </a>",
"    ]. The heptavalent formulation replaces earlier formulations and was approved by the US Food and Drug Administration (FDA) in 2013 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/47\">",
"     47",
"    </a>",
"    ]. It is maintained in the Strategic National Stockpile and distributed through the CDC&rsquo;s drug service.",
"   </p>",
"   <p>",
"    Regional Poison Centers across the United States may also be of assistance in contacting on call State Health Department Representatives after hours (calling 1-800-222-1222 automatically forwards the caller to the regional Poison Center). If there is no response, the CDC Director's Emergency Operations Center should be contacted (770-488-7100) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When botulism is suspected, the clinician should contact the State Health Department immediately for assistance with the decision of whether botulism antitoxin is indicated and to obtain a supply of antitoxin. If the clinical suspicion for botulism is high and symptoms are progressing, antitoxin should be administered as soon as possible and should not be delayed while awaiting results of diagnostic studies. Since equine botulinum toxin can cause sensitization and anaphylaxis, it should only be given to individuals thought to be at high risk for the disease based on clinical presentation and history suggestive of exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/43,48\">",
"     43,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy of heptavalent botulism antitoxin was evaluated in animals because it is not feasible or ethical to conduct efficacy studies in humans [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/47\">",
"     47",
"    </a>",
"    ]. Based on these animal data, the FDA has stated that heptavalent botulism antitoxin is likely to benefit humans with botulism. Observational studies have evaluated the effectiveness of botulism antitoxin preparations in humans:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One retrospective review of 132 patients with type A foodborne botulism showed that antitoxin therapy with a trivalent preparation decreased fatality rates compared to untreated patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/49\">",
"       49",
"      </a>",
"      ]. Antitoxin treatment initiated after 24 hours of symptom onset did not shorten the duration of symptoms, but did decrease fatality rates.",
"     </li>",
"     <li>",
"      In the outbreak in Thailand related to contaminated bamboo shoots, patients who received antitoxin on day four compared to those who received treatment on day six had a significantly reduced duration of mechanical ventilation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The safety of the heptavalent botulism antitoxin was evaluated in 40 healthy human volunteers and 228 patients who received it via the CDC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/47\">",
"     47",
"    </a>",
"    ]. The most commonly observed adverse effects were headache, fever, chills, rash, itching, and nausea. Because antitoxin is derived from horse serum, anaphylaxis and serum sickness may occur. Past reviews have reported incidences of 20 percent for serum sickness and 3 percent for anaphylaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/50\">",
"     50",
"    </a>",
"    ]. Guidelines for skin testing, desensitization, and dosing are included in the antitoxin prescribing information.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Human-derived botulinum immune globulin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human-derived botulinum immune globulin (called BIG-IV or BabyBIG) is available for intravenous use in infants less than one year of age who are diagnosed with infant botulism. BIG-IV should be administered as early as possible in the illness. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/10/166?source=see_link&amp;anchor=H14#H14\">",
"     \"Neuromuscular junction disorders in newborns and infants\", section on 'Infant botulism'",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/39/12916?source=see_link\">",
"     \"Botulism immune globulin (intravenous human): Drug information\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotic therapy is unproven by clinical trial, but widely used and recommended for wound botulism after antitoxin has been administered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/51\">",
"     51",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/42/22183?source=see_link\">",
"     Penicillin G",
"    </a>",
"    (3 million units IV every four hours in adults) provides effective coverage of other clostridial species and is frequently used.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"     Metronidazole",
"    </a>",
"    (500 mg IV every eight hours) is a possible alternative for penicillin-allergic patients. Because of the risk of polymicrobial infection in cases of wound botulism, patients with this form of the disease should promptly receive antimicrobial therapy, especially if presenting with leukocytosis, fever, an abscess, or cellulitis. Therapy may need to be broadened in wound botulism to cover other organisms recovered from the wound. However, the use of aminoglycosides is contraindicated, since they have been reported to induce neuromuscular blockade, potentiating the effects of the toxin in these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/52\">",
"     52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/10/166?source=see_link&amp;anchor=H13#H13\">",
"     \"Neuromuscular junction disorders in newborns and infants\", section on 'Aminoglycoside toxicity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antibiotics are",
"    <strong>",
"     not",
"    </strong>",
"    recommended for infant botulism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/51\">",
"     51",
"    </a>",
"    ] or for adults with suspected gastrointestinal botulism because lysis of intraluminal C. botulinum could increase the amount of toxin available for absorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/48,53\">",
"     48,53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/10/166?source=see_link&amp;anchor=H14#H14\">",
"     \"Neuromuscular junction disorders in newborns and infants\", section on 'Infant botulism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Other treatments",
"    </span>",
"    &nbsp;&mdash;&nbsp;In cases of foodborne botulism, laxatives, enemas, or other cathartics may be given, provided no significant ileus is present. Patients presenting with wound botulism should undergo extensive debridement, even if the wound appears unimpressive. These patients should receive tetanus boosters as well if it has been five or more years since their last immunization.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/5/31826?source=see_link\">",
"     Guanidine",
"    </a>",
"    , a drug that increases acetylcholine release at the neuromuscular junction, and plasmapheresis are experimental therapies that remain unproven in clinical trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1021334475\">",
"    <span class=\"h1\">",
"     VACCINE",
"    </span>",
"    &nbsp;&mdash;&nbsp;An investigational pentavalent botulinum toxoid vaccine was available from 1965 until 2011 from the United States Centers for Disease Control and Prevention (CDC) for use in individuals at risk for occupational exposure to botulinum serotypes A, B, C, D, and E [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/54\">",
"     54",
"    </a>",
"    ]. The CDC discontinued the availability of this vaccine in 2011 due to a decline in the immunogenicity of the vaccine (which was manufactured more than 30 years earlier) and an increase in local reactions to the vaccine following booster doses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Botulism of any type usually requires hospitalization for one to three months. With prompt attention to the impending respiratory failure and supportive care, mortality in botulism ranges from less than 5 percent to 8 percent (including infants) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/2,36\">",
"     2,36",
"    </a>",
"    ]; since 1980, the case-fatality rate has been &le;4 percent among patients with foodborne botulism in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/29\">",
"     29",
"    </a>",
"    ]. The mortality rate for infant botulism, the most common form in the United States, is less than 1 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/42\">",
"     42",
"    </a>",
"    ]. Initial misdiagnosis and disease caused by toxin type A are both associated with fatal outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A retrospective review of 706 patients hospitalized for foodborne botulism in the Republic of Georgia, which has the highest reported rate of foodborne botulism in the world, suggested that the prognosis can be estimated based upon the manifestations of the disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/36\">",
"     36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Shortness of breath alone identified patients at increased mortality risk (18 versus 1 percent without this symptom). In addition, shortness of breath was present in 50 of the 54 patients who died.",
"     </li>",
"     <li>",
"      In comparison, there were no deaths among 209 patients without shortness of breath, facial muscle weakness, or vomiting.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Prospective validation of these observations is necessary.",
"   </p>",
"   <p>",
"    Overall, most patients with prompt hospitalization and respiratory care can expect a complete or nearly complete recovery with return to previous level of functioning. Long-term morbidity is low in patients with mild disease, with complete resolution of symptoms generally occurring within the first three months. In comparison, patients with severe disease may experience protracted courses involving years of neurologic deficits, sequelae from extended mechanical ventilation, and nosocomial illness.",
"   </p>",
"   <p>",
"    The largest reported experience on the long-term outcomes after acute paralytic botulism comes from a case-control study of 217 such patients in the Republic of Georgia and three randomly selected community controls for each patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/36/37448/abstract/55\">",
"     55",
"    </a>",
"    ]. During the initial infection, 15 had been hospitalized for at least one month, and 25 percent required mechanical ventilation.",
"   </p>",
"   <p>",
"    The following findings were noted at a median of 4.3 years in the 211 patients who were still alive: 68 percent (compared to 17 percent of controls, matched odds ratio 17.6) reported their current health as being worse than six years before the interview; and 49 percent rated their health as fair or poor (compared to 25 percent of controls, matched odds ratio 5.0).",
"   </p>",
"   <p>",
"    Compared to controls, the patients were also significantly more likely to report symptoms such as fatigue, weakness, dizziness, difficulty breathing with moderate exertion, and impaired psychosocial well being. Requirement for mechanical ventilation during the acute illness and older age were independent predictors of worse long-term health.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Botulism is a rare but potentially life-threatening neuroparalytic syndrome resulting from the action of a neurotoxin elaborated by the bacterium Clostridium botulinum. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      C. botulinum is a heterogeneous group of gram-positive, rod-shaped, spore-forming, obligate anaerobic bacteria. They are ubiquitous and are easily isolated from the surfaces of vegetables, fruits, seafood, and exist in soil and marine sediment worldwide. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Five forms of botulism exist, including foodborne botulism, infant botulism, wound botulism, adult enteric infectious botulism, and inhalational botulism. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An average of 110 cases of botulism are reported each year in the United States according to the Centers for Disease Control and Prevention (CDC). Approximately 72 percent of cases are infant botulism, 25 percent are foodborne botulism, and the remaining 3 percent wound botulism. Adult infectious botulism is only occasionally reported. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Incidence by mode of acquisition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Botulism is classically described as the acute onset of bilateral cranial neuropathies associated with symmetric descending weakness. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although the isolation of spores",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      toxin can be helpful to establish the diagnosis, the most important issue is the initial consideration of the disease. A careful history and physical examination are essential. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Any patient with clinical signs, symptoms, or history suspicious for botulism should be hospitalized immediately and meticulously monitored for signs of respiratory failure. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are two botulism antitoxin therapies available in the United States. Equine serum heptavalent botulism antitoxin is used to treat children older than one year of age and adults; human-derived",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/39/12916?source=see_link\">",
"       botulism immune globulin",
"      </a>",
"      is used for infants less than one year of age. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Antitoxin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When botulism is suspected, the clinician should contact the State Health Department immediately for assistance with the decision of whether botulism antitoxin is indicated and to obtain a supply of antitoxin. If the clinical suspicion for botulism is high and symptoms are progressing, antitoxin should be administered as soon as possible and should not be delayed while awaiting results of diagnostic studies. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Equine serum botulism antitoxin'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/10/166?source=see_link\">",
"       \"Neuromuscular junction disorders in newborns and infants\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Antibiotics are recommended for wound botulism after antitoxin has been administered.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?21/42/22183?source=see_link\">",
"       Penicillin G",
"      </a>",
"      (3 million units IV every four hours in adults) provides effective coverage of other clostridial species and is frequently used.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"       Metronidazole",
"      </a>",
"      (500 mg IV every eight hours) is a possible alternative for penicillin-allergic patients. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Antibiotics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Antibiotics are not recommended for infant botulism or for adults with suspected gastrointestinal botulism because lysis of intraluminal C. botulinum could increase the amount of toxin available for absorption. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Antibiotics'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Kerner, J. Neue Beobachtungen uber die in Wurtemburg so haufig vorfallen Vergiftung durch den Genuss gerauchter Wurst. Tubingen, 1820. Quoted in: Damon, SR, Food Infections and Food Intoxications. Williams and Wilkins, Baltimore 1928. p.67.",
"    </li>",
"    <li>",
"     Abrutyn E. Botulism. In: Principles of Internal Medicine, 14th ed, Fauci AS, Isselbacher KJ, Braunwald E (Eds), McGraw-Hill, New York 1998. p.904.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/3\">",
"      Chertow DS, Tan ET, Maslanka SE, et al. Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation. JAMA 2006; 296:2476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/4\">",
"      Dowell VR Jr. Botulism and tetanus: selected epidemiologic and microbiologic aspects. Rev Infect Dis 1984; 6 Suppl 1:S202.",
"     </a>",
"    </li>",
"    <li>",
"     Bleck TP. Clostridium botulinum (botulism). In: Principles and Practice of Infectious Diseases, 6th ed, Mandel, GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, Philadelphia 2005. p.2822.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/6\">",
"      Aureli P, Fenicia L, Pasolini B, et al. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis 1986; 154:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/7\">",
"      Jin R, Rummel A, Binz T, Brunger AT. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity. Nature 2006; 444:1092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/8\">",
"      Chai Q, Arndt JW, Dong M, et al. Structural basis of cell surface receptor recognition by botulinum neurotoxin B. Nature 2006; 444:1096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/9\">",
"      Black JD, Dolly JO. Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis. J Cell Biol 1986; 103:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/10\">",
"      Sugiyama H. Clostridium botulinum neurotoxin. Microbiol Rev 1980; 44:419.",
"     </a>",
"    </li>",
"    <li>",
"     Middlebrook, JL. Relative lethality of selected toxins. Figure In: Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning, 2nd ed, Ellenhorn, MJ, Schonwald, S, Ordog, G, et al (Eds), Williams and Wilkins, Baltimore 1997. p.1055.",
"    </li>",
"    <li>",
"     Mcnally RE, Morrison MB, Berndt JE, et al. Effectiveness of medical defense interventions against predicted battlefield levels of botulinum toxin A, Science Applications International Corp, Joppa 1994.",
"    </li>",
"    <li>",
"     Wannemacher, RW Jr, Dinterman, RE, Thompson, WL, et al. Treatment for removal of biotoxins from drinking water. Fort Detrick, Frederick, MD: US Army Biomedical Research and Development Laboratory. Technical report 9120.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/14\">",
"      Pickett J, Berg B, Chaplin E, Brunstetter-Shafer MA. Syndrome of botulism in infancy: clinical and electrophysiologic study. N Engl J Med 1976; 295:770.",
"     </a>",
"    </li>",
"    <li>",
"     Dodds KL. Worldwide incidence and ecology of infant botulism. In: Clostridium botulinum: Ecology and control in foods, Hauschild AHW, Dodds KL (Eds), Marcel Dekker, New York 1993. Vol 108.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/16\">",
"      Werner SB, Passaro D, McGee J, et al. Wound botulism in California, 1951-1998: recent epidemic in heroin injectors. Clin Infect Dis 2000; 31:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/17\">",
"      Passaro DJ, Werner SB, McGee J, et al. Wound botulism associated with black tar heroin among injecting drug users. JAMA 1998; 279:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/18\">",
"      Sam AH, Beynon HL. Images in clinical medicine: Wound botulism. N Engl J Med 2010; 363:2444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/19\">",
"      Yuan J, Inami G, Mohle-Boetani J, Vugia DJ. Recurrent wound botulism among injection drug users in California. Clin Infect Dis 2011; 52:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/20\">",
"      Roblot F, Popoff M, Carlier JP, et al. Botulism in patients who inhale cocaine: the first cases in France. Clin Infect Dis 2006; 43:e51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/21\">",
"      Sobel J, Tucker N, Sulka A, et al. Foodborne botulism in the United States, 1990-2000. Emerg Infect Dis 2004; 10:1606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/22\">",
"      Mazuet C, Ezan E, Volland H, et al. Toxin detection in patients' sera by mass spectrometry during two outbreaks of type A Botulism in France. J Clin Microbiol 2012; 50:4091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/23\">",
"      Townes JM, Cieslak PR, Hatheway CL, et al. An outbreak of type A botulism associated with a commercial cheese sauce. Ann Intern Med 1996; 125:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/24\">",
"      Centers for Disease Control and Prevention (CDC). Botulism associated with commercial carrot juice--Georgia and Florida, September 2006. MMWR Morb Mortal Wkly Rep 2006; 55:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/25\">",
"      Sheth AN, Wiersma P, Atrubin D, et al. International outbreak of severe botulism with prolonged toxemia caused by commercial carrot juice. Clin Infect Dis 2008; 47:1245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/26\">",
"      Zhang S, Wang Y, Qiu S, et al. Multilocus outbreak of foodborne botulism linked to contaminated sausage in Hebei province, China. Clin Infect Dis 2010; 51:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/27\">",
"      Centers for Disease Control and Prevention (CDC). Notes from the field: Botulism caused by consumption of commercially produced potato soups stored improperly--Ohio and Georgia, 2011. MMWR Morb Mortal Wkly Rep 2011; 60:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/28\">",
"      Juliao PC, Maslanka S, Dykes J, et al. National outbreak of type a foodborne botulism associated with a widely distributed commercially canned hot dog chili sauce. Clin Infect Dis 2013; 56:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/29\">",
"      Fagan RP, McLaughlin JB, Castrodale LJ, et al. Endemic foodborne botulism among Alaska Native persons--Alaska, 1947-2007. Clin Infect Dis 2011; 52:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/30\">",
"      Austin JW, Leclair D. Botulism in the North: a disease without borders. Clin Infect Dis 2011; 52:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/31\">",
"      Centers for Disease Control and Prevention (CDC). Botulism from home-canned bamboo shoots--Nan Province, Thailand, March 2006. MMWR Morb Mortal Wkly Rep 2006; 55:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/32\">",
"      Kongsaengdao S, Samintarapanya K, Rusmeechan S, et al. An outbreak of botulism in Thailand: clinical manifestations and management of severe respiratory failure. Clin Infect Dis 2006; 43:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/33\">",
"      Centers for Disease Control and Prevention (CDC). Notes from the field: botulism from drinking prison-made illicit alcohol - Arizona, 2012. MMWR Morb Mortal Wkly Rep 2013; 62:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/34\">",
"      Sobel J. Botulism. Clin Infect Dis 2005; 41:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/35\">",
"      Sobel J, Malavet M, John S. Outbreak of clinically mild botulism type E illness from home-salted fish in patients presenting with predominantly gastrointestinal symptoms. Clin Infect Dis 2007; 45:e14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/36\">",
"      Varma JK, Katsitadze G, Moiscrafishvili M, et al. Signs and symptoms predictive of death in patients with foodborne botulism--Republic of Georgia, 1980-2002. Clin Infect Dis 2004; 39:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/37\">",
"      Hughes JM, Blumenthal JR, Merson MH, et al. Clinical features of types A and B food-borne botulism. Ann Intern Med 1981; 95:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/38\">",
"      Mechem CC, Walter FG. Wound botulism. Vet Hum Toxicol 1994; 36:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/39\">",
"      Nystrom SC, Wells EV, Pokharna HS, et al. Botulism toxemia following laparoscopic appendectomy. Clin Infect Dis 2012; 54:e32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/40\">",
"      O'Suilleabhain P, Low PA, Lennon VA. Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome: serologic and clinical correlates. Neurology 1998; 50:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/41\">",
"      Roland EH, Ebelt VJ, Anderson JD, Hill A. Infant botulism: a rare entity in Canada? CMAJ 1986; 135:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/42\">",
"      Arnon SS, Schechter R, Maslanka SE, et al. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med 2006; 354:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/43\">",
"      Fagan RP, McLaughlin JB, Middaugh JP. Persistence of botulinum toxin in patients' serum: Alaska, 1959-2007. J Infect Dis 2009; 199:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/44\">",
"      Wheeler C, Inami G, Mohle-Boetani J, Vugia D. Sensitivity of mouse bioassay in clinical wound botulism. Clin Infect Dis 2009; 48:1669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/45\">",
"      Schreiner MS, Field E, Ruddy R. Infant botulism: a review of 12 years' experience at the Children's Hospital of Philadelphia. Pediatrics 1991; 87:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/46\">",
"      Centers for Disease Control and Prevention (CDC). Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E. MMWR Morb Mortal Wkly Rep 2010; 59:299.",
"     </a>",
"    </li>",
"    <li>",
"     FDA news release. FDA approves first botulism antitoxin for use in neutralizing all seven known botulinum nerve toxin serotypes. file://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345128.htm (Accessed on March 25, 2013).",
"    </li>",
"    <li>",
"     United States Centers for Disease Control and Prevention. Botulism in the United States 1899-1996: Handbook for Epidemiologists, Clinicians &amp; Laboratory Workers, 1998. file://www.cdc.gov/ncidod/dbmd/diseaseinfo/files/botulism.pdf (Accessed on April 12, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/49\">",
"      Tacket CO, Shandera WX, Mann JM, et al. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. Am J Med 1984; 76:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/50\">",
"      Sellin LC. Botulism--an update. Mil Med 1984; 149:12.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Botulism and infant botulism (Clostridium botulinum). In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th ed, Pickering, LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.281.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/52\">",
"      Santos JI, Swensen P, Glasgow LA. Potentiation of Clostridium botulinum toxin aminoglycoside antibiotics: clinical and laboratory observations. Pediatrics 1981; 68:50.",
"     </a>",
"    </li>",
"    <li>",
"     Reddy P, Bleck TP. Clostridium botulinum (Botulism). In: Principles and Practice of Infectious Diseases, 7th ed, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone Elsevier, Philadelphia 2010. p.3097.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/54\">",
"      Centers for Disease Control and Prevention (CDC). Notice of CDC's discontinuation of investigational pentavalent (ABCDE) botulinum toxoid vaccine for workers at risk for occupational exposure to botulinum toxins. MMWR Morb Mortal Wkly Rep 2011; 60:1454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/36/37448/abstract/55\">",
"      Gottlieb SL, Kretsinger K, Tarkhashvili N, et al. Long-term outcomes of 217 botulism cases in the Republic of Georgia. Clin Infect Dis 2007; 45:174.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5509 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-88.81.100.162-4217E6CC24-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_36_37448=[""].join("\n");
var outline_f36_36_37448=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11649389\">",
"      TYPES OF BOTULISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Incidence by mode of acquisition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Sources",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Wounds",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Foodborne botulism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Infant botulism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Infant botulism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Foodborne botulism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Wound botulism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Adult infectious botulism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Infant botulism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Foodborne botulism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Wound botulism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Adult enteric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Antitoxin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Equine serum botulism antitoxin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Human-derived botulinum immune globulin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Other treatments",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1021334475\">",
"      VACCINE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?12/39/12916?source=related_link\">",
"      Botulism immune globulin (intravenous human): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/46/22247?source=related_link\">",
"      Identifying and managing casualties of biological terrorism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/10/166?source=related_link\">",
"      Neuromuscular junction disorders in newborns and infants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_36_37449="Olanzapine: Drug information";
var content_f36_36_37449=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Olanzapine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?28/16/28934?source=see_link\">",
"    see \"Olanzapine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/24/34185?source=see_link\">",
"    see \"Olanzapine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5709177\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F203156\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      ZyPREXA&reg;;",
"     </li>",
"     <li>",
"      ZyPREXA&reg; IntraMuscular;",
"     </li>",
"     <li>",
"      ZyPREXA&reg; Relprevv&trade;;",
"     </li>",
"     <li>",
"      ZyPREXA&reg; Zydis&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F203157\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Olanzapine ODT&reg;;",
"     </li>",
"     <li>",
"      Apo-Olanzapine&reg;;",
"     </li>",
"     <li>",
"      Ava-Olanzapine;",
"     </li>",
"     <li>",
"      CO Olanzapine;",
"     </li>",
"     <li>",
"      CO Olanzapine ODT;",
"     </li>",
"     <li>",
"      Mylan-Olanzapine;",
"     </li>",
"     <li>",
"      Olanzapine ODT;",
"     </li>",
"     <li>",
"      PHL-Olanzapine;",
"     </li>",
"     <li>",
"      PHL-Olanzapine ODT;",
"     </li>",
"     <li>",
"      PMS-Olanzapine;",
"     </li>",
"     <li>",
"      PMS-Olanzapine ODT;",
"     </li>",
"     <li>",
"      Riva-Olanzapine;",
"     </li>",
"     <li>",
"      Riva-Olanzapine ODT;",
"     </li>",
"     <li>",
"      Sandoz-Olanzapine;",
"     </li>",
"     <li>",
"      Sandoz-Olanzapine ODT;",
"     </li>",
"     <li>",
"      Teva-Olanzapine;",
"     </li>",
"     <li>",
"      Teva-Olanzapine OD;",
"     </li>",
"     <li>",
"      Zyprexa&reg;;",
"     </li>",
"     <li>",
"      Zyprexa&reg; Intramuscular;",
"     </li>",
"     <li>",
"      Zyprexa&reg; Zydis&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F203198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antimanic Agent;",
"     </li>",
"     <li>",
"      Antipsychotic Agent, Atypical",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F203161\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Schizophrenia:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Initial: 5-10 mg once daily (increase to 10 mg once daily within 5-7 days); thereafter, adjust by 5 mg/day at 1-week intervals, up to a recommended maximum of 20 mg/day. Maintenance: 10-20 mg once daily. Doses of 30-50 mg/day have been used; however, doses &gt;10 mg/day have not demonstrated better efficacy, and safety and efficacy of doses &gt;20 mg/day have not been evaluated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Extended-release I.M. injection:",
"     <b>",
"      Note:",
"     </b>",
"     Establish tolerance to oral olanzapine prior to changing to extended-release I.M. injection. Maximum dose: 300 mg/2 weeks or 405 mg/4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Patients established on oral olanzapine 10 mg/day:",
"     </i>",
"     Initial dose: 210 mg every 2 weeks for 4 doses or 405 mg every 4 weeks for 2 doses; Maintenance dose: 150 mg every 2 weeks or 300 mg every 4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Patients established on oral olanzapine 15 mg/day:",
"     </i>",
"     Initial dose: 300 mg every 2 weeks for 4 doses; Maintenance dose: 210 mg every 2 weeks or 405 mg every 4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Patients established on oral olanzapine 20 mg/day:",
"     </i>",
"     Initial and maintenance dose: 300 mg every 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Acute mania associated with bipolar disorder:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Monotherapy:",
"     </i>",
"     Initial: 10-15 mg once daily; increase by 5 mg/day at intervals of not less than 24 hours. Maintenance: 5-20 mg/day; recommended maximum dose: 20 mg/day.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Combination therapy",
"     </i>",
"     (with lithium or valproate): Initial: 10 mg once daily; dosing range: 5-20 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Agitation (acute, associated with bipolar disorder or schizophrenia):",
"     </b>",
"     Short-acting I.M. injection: Initial dose: 10 mg (a lower dose of 5-7.5 mg may be considered when clinical factors warrant); additional doses (up to 10 mg) may be considered; however, 2-4 hours should be allowed between doses to evaluate response (maximum total daily dose: 30 mg, per manufacturer's recommendation)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Depression:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Depression associated with bipolar disorder (in combination with fluoxetine):",
"     </i>",
"     Oral: Initial: 5 mg in the evening; adjust as tolerated to usual range of 5-12.5 mg/day. See",
"     <b>",
"      \"Note.\"",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Treatment-resistant depression (in combination with fluoxetine):",
"     </i>",
"     Oral: Initial: 5 mg in the evening; adjust as tolerated to range of 5-20 mg/day. See",
"     <b>",
"      \"Note.\"",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     When using individual components of fluoxetine with olanzapine rather than fixed dose combination product (Symbyax&reg;), approximate dosage correspondence is as follows:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Olanzapine 2.5 mg + fluoxetine 20 mg = Symbyax&reg; 3/25",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Olanzapine 5 mg + fluoxetine 20 mg = Symbyax&reg; 6/25",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Olanzapine 12.5 mg + fluoxetine 20 mg = Symbyax&reg; 12/25",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Olanzapine 5 mg + fluoxetine 50 mg = Symbyax&reg; 6/50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Olanzapine 12.5 mg + fluoxetine 50 mg = Symbyax&reg; 12/50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Delirium (unlabeled use):",
"     </b>",
"     Oral: 5 mg once daily for up to 5 days (NICE, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Prevention of chemotherapy-associated delayed nausea or vomiting (unlabeled use; in combination with a corticosteroid and serotonin [5-HT",
"      <sub>",
"       3",
"      </sub>",
"      ] antagonist):",
"     </b>",
"     Oral: 10 mg once daily for 3-5 days, beginning on day 1 of chemotherapy",
"     <b>",
"      or",
"     </b>",
"     5 mg once daily for 2 days before chemotherapy, followed by 10 mg once daily (beginning on the day of chemotherapy) for 3-8 days",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F203180\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/24/34185?source=see_link\">",
"      see \"Olanzapine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Schizophrenia/bipolar disorder:",
"     </b>",
"     Adolescents &ge;13 years: Oral: Initial: 2.5-5 mg once daily; adjust by 2.5-5 mg/day to target dose of 10 mg/day; dosing range: 2.5-20 mg/ day",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F203162\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Short-acting I.M., Oral: Consider lower starting dose of 2.5-5 mg/day for elderly or debilitated patients; may increase as clinically indicated and tolerated with close monitoring of orthostatic blood pressure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Extended release I.M.: Consider lower starting dose of 150 mg every 4 weeks for elderly or debilitated patients; increase dose with caution as clinically indicated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Delirium (unlabeled use): Oral: Patients &gt;60 years: Oral: 2.5 mg/day for up to 5 days (NICE, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Psychosis/agitation related to Alzheimer&rsquo;s dementia (unlabeled use): Oral: Initial: 2.5-5 mg/day (Sultzer, 2008)",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F203163\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment required. Not removed by dialysis.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F203164\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dosage adjustment may be necessary; however, there are no specific recommendations. Monitor closely.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F203131\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution: 10 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ZyPREXA&reg; IntraMuscular: 10 mg [contains lactose 50 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for suspension, extended release:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ZyPREXA&reg; Relprevv&trade;: 210 mg, 300 mg, 405 mg [contains polysorbate 80 (in diluent); supplied with diluent]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ZyPREXA&reg;: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, orally disintegrating, oral: 5 mg, 10 mg, 15 mg, 20 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ZyPREXA&reg; Zydis&reg;: 5 mg [contains phenylalanine 0.34 mg/tablet]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ZyPREXA&reg; Zydis&reg;: 10 mg [contains phenylalanine 0.45 mg/tablet]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ZyPREXA&reg; Zydis&reg;: 15 mg [contains phenylalanine 0.67 mg/tablet]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ZyPREXA&reg; Zydis&reg;: 20 mg [contains phenylalanine 0.9 mg/tablet]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F203116\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes Injection (powder for suspension, extended release)",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11238295\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     As a requirement of the REMS program, only prescribers, healthcare facilities, and pharmacies registered with the Zyprexa&reg; Relprevv&trade; Patient Care Program are able to prescribe, distribute, or dispense Zyprexa&reg; Relprevv&trade; for patients who are enrolled in and meet all conditions of the program. Zyprexa&reg; Relprevv&trade; must be administered at a registered healthcare facility. Prescribers will need to be recertified every 3 years. Contact the Zyprexa&reg; Relprevv&trade; Patient Care Program at 1-877-772-9390.",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874938\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and as follows, must be dispensed with this medication:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Zyprexa&reg; and Zyprexa&reg; Zydis:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM134700.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM134700.pdf",
"     </a>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Zyprexa&reg; Relprevv&trade;:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM194579.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM194579.pdf",
"     </a>",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F203135\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Short-acting I.M. injection:",
"     <b>",
"      For I.M. administration only",
"     </b>",
"     ; do not administer injection intravenously or subcutaneously; inject slowly, deep into muscle. If dizziness and/or drowsiness are noted, patient should remain recumbent until examination indicates postural hypotension and/or bradycardia are not a problem.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Extended-release I.M. injection:",
"     <b>",
"      For I.M. gluteal injection only",
"     </b>",
"     ; do not administer I.V. or subcutaneously. After needle insertion into muscle, aspirate to verify that no blood appears. Do not massage injection site. Use diluent, syringes, and needles provided in convenience kit; obtain a new kit if aspiration of blood occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet: May be administered without regard to meals.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Orally-disintegrating: Remove from foil blister by peeling back (do not push tablet through the foil); place tablet in mouth immediately upon removal; tablet dissolves rapidly in saliva and may be swallowed with or without liquid. May be administered with or without food/meals.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F203134\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: Treatment of the manifestations of schizophrenia; treatment of acute or mixed mania episodes associated with bipolar I disorder (as monotherapy or in combination with lithium or valproate); maintenance treatment of bipolar disorder; in combination with fluoxetine for treatment-resistant or bipolar I depression",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.M., extended-release (Zyprexa&reg; Relprevv&trade;): Treatment of schizophrenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.M., short-acting (Zyprexa&reg; IntraMuscular): Treatment of acute agitation associated with schizophrenia and bipolar I mania",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F203194\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of psychosis/schizophrenia in children; chronic pain; prevention of chemotherapy-associated delayed nausea or vomiting; psychosis/agitation related to Alzheimer&rsquo;s dementia; acute treatment of delirium",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F203206\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       OLANZapine may be confused with olsalazine, QUEtiapine",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       ZyPREXA&reg; may be confused with CeleXA&reg;, Reprexain&trade;, Zestril&reg;, ZyrTEC&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       ZyPREXA&reg; Zydis&reg; may be confused with Zelapar&reg;, zolpidem",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       ZyPREXA&reg; Relprevv&trade; may be confused with ZyPREXA&reg; IntraMuscular",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F203196\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Oral:",
"     </b>",
"     Unless otherwise noted, adverse events are reported for placebo-controlled trials in adult patients on monotherapy:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Somnolence (dose dependent; 20% to 39%; adolescents 39% to 48%), extrapyramidal symptoms (dose dependent; &le;32%), dizziness (11% to 18%), headache (adolescents 17%), fatigue (adolescents 3% to 14%), insomnia (12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Prolactin increased (30%; adolescents 47%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Weight gain (5% to 6%, has been reported as high as 40%; adolescents 29% to 31%), appetite increased (3% to 6%; adolescents 17% to 29%), xerostomia (dose dependent; 3% to 22%), constipation (9% to 11%), dyspepsia (7% to 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: ALT increased &ge;3 x ULN (adolescents 12%; adults 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Weakness (dose dependent; 8% to 20%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Accidental injury (12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Chest pain, hypertension, orthostatic hypotension, peripheral edema, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fever, personality changes, restlessness (adolescents)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Bruising",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Breast-related events ([adolescents] discharge, enlargement, galactorrhea, gynecomastia, lactation disorder); menstrual-related events (amenorrhea, hypomenorrhea, menstruation delayed, oligomenorrhea); sexual function-related events (anorgasmia, ejaculation delayed, erectile dysfunction, changes in libido, abnormal orgasm, sexual dysfunction)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain (adolescents), diarrhea (adolescents), flatulence, nausea (dose dependent), vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Incontinence, UTI",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Hepatic enzymes increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Abnormal gait, akathisia, articulation impairment, back pain, falling, hypertonia, joint/extremity pain, muscle stiffness (adolescents), tremor (dose dependent)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Amblyopia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Cough, epistaxis (adolescents), pharyngitis, respiratory tract infection (adolescents), rhinitis, sinusitis (adolescents)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Acidosis, agranulocytosis, anaphylactoid reaction, angioedema, apnea, atelectasis, atrial fibrillation, cerebrovascular accident, congestive heart failure, deafness, diabetes mellitus, diabetic ketoacidosis, diabetic coma, dystonia, encephalopathy, facial paralysis, glaucoma, heart arrest, heart failure, hemorrhage (eye, rectal, subarachnoid, vaginal), hepatitis, hypercholesterolemia, hyper-/hypoglycemia, hyper-/hypokalemia, hyperlipemia, hyper-/hyponatremia, hypertriglyceridemia, hyperuricemia, hyper-/hypoventilation, hypoproteinemia, hypoxia, jaundice, ileus, ketosis, leukocytosis (eosinophilia), leukopenia, liver damage (cholestatic or mixed), liver fatty deposit, lung edema, lymphadenopathy, myasthenia, myopathy, neuralgia, neuroleptic malignant syndrome, neutropenia, pancreatitis, paralysis, pulmonary embolus, rash, rhabdomyolysis, seizure, sudden death, suicide attempt, syncope, tardive dyskinesia, thrombocythemia, thrombocytopenia, transient ischemic attack, venous thrombotic events",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Injection:",
"     </b>",
"     Unless otherwise noted, adverse events are reported for placebo-controlled trials in adult patients on extended-release I.M. injection (Zyprexa&reg; Relprevv&trade;). Also refer to adverse reactions noted with oral therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     &gt;10%: Central nervous system: Headache (13% to 18%), sedation (8% to 13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Cardiovascular: Hypertension, hypotension (short-acting), orthostatic hypotension (short-acting), QT prolongation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Central nervous system: Abnormal dreams, abnormal thinking, auditory hallucination, dizziness, dysarthria, extrapyramidal symptoms, fatigue, fever, pain, restlessness, somnolence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Dermatologic: Acne",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, appetite increased, diarrhea, flatulence, nausea, vomiting, weight gain, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Genitourinary: Vaginal discharge",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Hepatic: Liver enzymes increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Local: Injection site pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, back pain, muscle spasms, stiffness, tremor, weakness (short-acting)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Otic: Ear pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Respiratory: Cough, nasal congestion, nasopharyngitis, pharyngolaryngeal pain, sneezing, upper respiratory tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Miscellaneous: Toothache, tooth infection, viral infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): CPK increased, post-injection delirium/sedation syndrome, syncope (short-acting)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F203138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     There are no contraindications listed in the manufacturer&rsquo;s labeling.",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;\">",
"     Canadian labeling: Hypersensitivity to olanzapine or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F203120\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Altered cardiac conduction: May alter cardiac conduction; life-threatening arrhythmias have occurred with therapeutic doses of antipsychotics.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anticholinergic effects: May cause anticholinergic effects (constipation, xerostomia, blurred vision, urinary retention); use with caution in patients with decreased gastrointestinal motility, paralytic ileus, urinary retention, BPH, xerostomia, or visual problems (including narrow-angle glaucoma). Relative to other neuroleptics, olanzapine has a moderate potency of cholinergic blockade.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Blood dyscrasias: Leukopenia, neutropenia, and agranulocytosis (sometimes fatal) have been reported in clinical trials and postmarketing reports with antipsychotic use; presence of risk factors (eg, pre-existing low WBC or history of drug-induced leuko-/neutropenia) should prompt periodic blood count assessment. Discontinue therapy at first signs of blood dyscrasias or if absolute neutrophil count &lt;1000/mm",
"     <sup>",
"      3",
"     </sup>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cerebrovascular effects: An increased incidence of cerebrovascular effects (eg, transient ischemic attack, stroke), including fatalities, has been reported in placebo-controlled trials of olanzapine for the unapproved use in elderly patients with dementia-related psychosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Esophageal dysmotility/aspiration: Antipsychotic use has been associated with esophageal dysmotility and aspiration; use with caution in patients at risk of pneumonia (ie, Alzheimer's disease).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Extrapyramidal symptoms (EPS): May cause extrapyramidal symptoms, including pseudoparkinsonism, acute dystonic reactions, akathisia, and tardive dyskinesia (risk of these reactions is generally much lower relative to typical/conventional antipsychotics). Risk of dystonia (and probably other EPS) may be greater with increased doses, use of conventional antipsychotics, males, and younger patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperglycemia: Atypical antipsychotics have been associated with development of hyperglycemia; in some cases, may be extreme and associated with ketoacidosis, hyperosmolar coma, or death. Olanzapine may have a greater association with hyperglycemia than other atypical antipsychotics. Use with caution in patients with diabetes or other disorders of glucose regulation; monitor for worsening of glucose control. Patients with risk factors for diabetes (eg, obesity or family history) should have a baseline fasting blood sugar (FBS) and periodic assessment of glucose regulation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperlipidemia: Increases in cholesterol and triglycerides have been noted. Use with caution in patients with pre-existing abnormal lipid profile.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperprolactinemia: May increase prolactin levels; clinical significance of hyperprolactinemia in patients with breast cancer or other prolactin-dependent tumors is unknown.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neuroleptic malignant syndrome (NMS): Use may be associated with NMS; monitor for mental status changes, fever, muscle rigidity, and/or autonomic instability.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Orthostatic hypotension: May cause orthostatic hypotension; use with caution in patients at risk of this effect or in those who would not tolerate transient hypotensive episodes (cerebrovascular disease, cardiovascular disease, hypovolemia, or concurrent medication use which may predispose to hypotension/bradycardia).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedation: May be moderate to highly sedating, use with caution in disorders where CNS depression is a feature; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Suicidal ideation: The possibility of a suicide attempt is inherent in psychotic illness or bipolar disorder; use with caution in high-risk patients during initiation of therapy. Prescriptions should be written for the smallest quantity consistent with good patient care.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Temperature regulation: Impaired core body temperature regulation may occur; caution with strenuous exercise, heat exposure, dehydration, and concomitant medication possessing anticholinergic effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Weight gain: Significant weight gain (&gt;7% of baseline weight) has been observed with antipsychotic therapy; incidence varies with product. Monitor waist circumference and BMI.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with severe cardiac disease, hemodynamic instability, prior myocardial infarction, ischemic heart disease, or hypercholesterolemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dementia:",
"     <b>",
"      [U.S. Boxed Warning]: Elderly patients with dementia-related psychosis treated with antipsychotics are at an increased risk of death compared to placebo.",
"     </b>",
"     Most deaths appeared to be either cardiovascular (eg, heart failure, sudden death) or infectious (eg, pneumonia) in nature. Olanzapine is not approved for the treatment of dementia-related psychosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic disease or impairment; may increase transaminases (primarily ALT).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Parkinson's disease: Use with caution in patients with Parkinson's disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizures: Use with caution in patients at risk of seizures, including those with a history of seizures, head trauma, brain damage, alcoholism, or concurrent therapy with medications which may lower seizure threshold. Elderly patients may be at increased risk of seizures due to an increased prevalence of predisposing factors.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adolescents: Use in patients &ge;13 years of age may result in increased weight gain and sedation, as well as greater increases in LDL cholesterol, total cholesterol, triglycerides, prolactin, and liver transaminase levels when compared to adults. Adolescent patients should be maintained on the lowest dose necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use in patients with dementia is associated with an increased risk of mortality and cerebrovascular accidents; avoid antipsychotic use for behavioral problems associated with dementia unless alternative nonpharmacologic therapies have failed and patient may harm self or others. In addition, use may cause or exacerbate syndrome of inappropriate antidiuretic hormone secretion or hyponatremia; monitor sodium closely with initiation or dosage adjustments in older adults. May also be inappropriate in older adults depending on comorbidities (eg, dementia, delirium) due to its potent anticholinergic effects  (Beers Criteria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Smokers: Olanzapine levels may be lower in patients who smoke; the manufacturer does not require dosage adjustments, although dosage adjustments may be considered.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form-specific concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Intramuscular formulations: There are two Zyprexa&reg; formulations for intramuscular injection: Zyprexa&reg; Relprevv&trade; is an extended-release formulation and Zyprexa&reg; IntraMuscular is short-acting.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Extended-release I.M. injection (Zyprexa&reg; Relprevv&trade;):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Post-injection delirium/sedation syndrome:",
"     <b>",
"      [U.S. Boxed Warning]: Sedation (including coma) and delirium (including agitation, anxiety, confusion, disorientation) have been observed following use of Zyprexa&reg; Relprevv&trade;;",
"     </b>",
"     events associated with an inadvertent rapid rise in serum concentrations; administer at a registered healthcare facility where patients should be continuously monitored (&ge;3 hours) for symptoms of olanzapine overdose; symptom development highest in first hour but may occur within or after 3 hours; risk of syndrome is cumulative with each injection; recovery expected by 72 hours. Upon determining alert status, patient should be escorted to their destination and not drive or operate heavy machinery for the remainder of the day.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Restricted distribution program: Zyprexa&reg; Relprevv&trade; is only available under a restricted distribution program. Only prescribers, healthcare facilities, and pharmacies registered with the program are able to prescribe, distribute, or dispense Zyprexa&reg; Relprevv&trade; for patients who are enrolled in and meet all conditions of the program.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Short-acting I.M. injection (Zyprexa&reg; IntraMuscular):",
"     </i>",
"     Patients should remain recumbent if drowsy/dizzy until hypotension, bradycardia, and/or hypoventilation have been ruled out. Closely monitor for orthostasis prior to any repeat dosing. Concurrent use of I.M./I.V. benzodiazepines is not recommended (fatalities have been reported, though causality not determined).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F203191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (major), CYP2D6 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak), CYP2C19 (weak), CYP2C9 (weak), CYP2D6 (weak), CYP3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F203125\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): May enhance the neurotoxic (central) effect of Antipsychotics. Severe extrapyramidal symptoms have occurred in some patients.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Antipsychotics may diminish the stimulatory effect of Amphetamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anti-Parkinson's Agents (Dopamine Agonist): Antipsychotics (Atypical) may diminish the therapeutic effect of Anti-Parkinson's Agents (Dopamine Agonist).  Management: Consider using an alternative antipsychotic agent when possible in patients with Parkinson's disease.  If an atypical antipsychotic is necessary, consider using clozapine or quetiapine, which may convey the lowest interaction risk.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzodiazepines: OLANZapine may enhance the adverse/toxic effect of Benzodiazepines.  Management: Avoid concomitant use of parenteral benzodiazepines and IM olanzapine due to risks of additive adverse events (e.g., cardiorespiratory depression). Olanzapine prescribing information provides no specific recommendations regarding oral administration.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inducers (Strong): May increase the metabolism of CYP1A2 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Moderate): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Strong): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproterone: May decrease the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FluvoxaMINE: May decrease the metabolism of OLANZapine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     LamoTRIgine: May enhance the sedative effect of OLANZapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium formulations: May enhance the neurotoxic effect of Antipsychotics. Lithium formulations may decrease the serum concentration of Antipsychotics. Specifically noted with chlorpromazine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: Antipsychotics may enhance the adverse/toxic effect of Methylphenidate. Methylphenidate may enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinagolide: Antipsychotics may diminish the therapeutic effect of Quinagolide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin Modulators: Antipsychotics may enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetrabenazine: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F203153\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: Avoid dong quai, St John's wort (may also cause photosensitization). Avoid kava kava, gotu kola, valerian, St John's wort (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F203127\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F2839122\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No evidence of teratogenicity reported in animal studies. However, fetal toxicity and prolonged gestation have been observed. Antipsychotic use during the third trimester of pregnancy has a risk for abnormal muscle movements (extrapyramidal symptoms [EPS]) and withdrawal symptoms in newborns following delivery. Symptoms in the newborn may include agitation, feeding disorder, hypertonia, hypotonia, respiratory distress, somnolence, and tremor; these effects may be self-limiting or require hospitalization. There are no adequate and well-controlled studies in pregnant women. Healthcare providers are encouraged to enroll women 18-45 years of age exposed to olanzapine during pregnancy in the Atypical Antipsychotics Pregnancy Registry (1-866-961-2388 or file://www.womensmentalhealth.org/pregnancyregistry).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F203169\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F2839124\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     At steady-state concentrations, it is estimated that a breast-fed infant may be exposed to ~2% of the maternal dose.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F203141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Tablets may be taken without regard to meals. Some products may contain phenylalanine.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F203140\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (OLANZapine Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (1): $36.25",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (ZyPREXA Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (1): $46.87",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension (reconstituted)",
"     </b>",
"     (ZyPREXA Relprevv Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     210 mg (1): $667.80",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     300 mg (1): $954.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     405 mg (1): $1287.90",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, orally-disintegrating",
"     </b>",
"     (OLANZapine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (30): $427.75",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (30): $628.51",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     15 mg (30): $926.90",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (30): $1225.30",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, orally-disintegrating",
"     </b>",
"     (ZyPREXA Zydis Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (1): $15.86",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (1): $23.30",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     15 mg (1): $34.37",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (1): $45.43",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (OLANZapine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5 mg (30): $335.55",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (30): $396.04",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     7.5 mg (30): $481.96",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (30): $596.79",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     15 mg (30): $895.19",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (30): $1193.58",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Zinc Sulfate Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     140 (50 Zn) mg (90): $5.49",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (ZyPREXA Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5 mg (30): $373.25",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (30): $440.53",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     7.5 mg (100): $1787.04",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (30): $663.84",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     15 mg (100): $3319.20",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (30): $1327.68",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F203129\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Vital signs; fasting lipid profile and fasting blood glucose/Hgb A",
"     <sub>",
"      1c",
"     </sub>",
"     (prior to treatment, at 3 months, then annually); periodic assessment of hepatic transaminases (in patients with hepatic disease); BMI, waist circumference; orthostatic blood pressure; mental status, abnormal involuntary movement scale (AIMS), extrapyramidal symptoms (EPS). Weight should be assessed prior to treatment, at 4 weeks, 8 weeks, 12 weeks, and then at quarterly intervals. Consider titrating to a different antipsychotic agent for a weight gain &ge;5% of the initial weight.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Extended-release I.M. injection: Sedation/delirium for 3 hours after each dose",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F203142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Dozic (CO);",
"     </li>",
"     <li>",
"      Midax (PY);",
"     </li>",
"     <li>",
"      Nodoff (TW);",
"     </li>",
"     <li>",
"      Okpine (TW);",
"     </li>",
"     <li>",
"      Olandoz (ID);",
"     </li>",
"     <li>",
"      Olanpin (KP);",
"     </li>",
"     <li>",
"      Olanza OD (KP);",
"     </li>",
"     <li>",
"      Olanzapro (PH);",
"     </li>",
"     <li>",
"      Olapin-10 (KP, TH);",
"     </li>",
"     <li>",
"      Oleanz (IN);",
"     </li>",
"     <li>",
"      Onzapin (SG);",
"     </li>",
"     <li>",
"      Onzapin ODT (SG);",
"     </li>",
"     <li>",
"      Ozapex (KP);",
"     </li>",
"     <li>",
"      Placet (PY, UY);",
"     </li>",
"     <li>",
"      Remital (ID);",
"     </li>",
"     <li>",
"      Zanprex (PH);",
"     </li>",
"     <li>",
"      Zapilux (BG);",
"     </li>",
"     <li>",
"      Zapinex (PH);",
"     </li>",
"     <li>",
"      Zelta (CO, DO, GT, HN, PA, SV);",
"     </li>",
"     <li>",
"      Zeprex (PH);",
"     </li>",
"     <li>",
"      Zypadhera (CZ, DE, DK, EE, FR, GB, IE, NL, NO, PT, SE);",
"     </li>",
"     <li>",
"      Zypeace OD (KP);",
"     </li>",
"     <li>",
"      Zyprexa (AR, AT, AU, BE, BF, BJ, BR, CH, CI, CL, CN, CO, CR, CZ, DE, DK, EE, ES, ET, FI, FR, GB, GH, GM, GN, GR, HK, ID, IE, IL, IT, KE, LR, MA, ML, MR, MT, MU, MW, MX, MY, NE, NG, NI, NL, NO, NZ, PE, PH, PK, PL, PT, RU, SC, SD, SE, SG, SK, SL, SN, TH, TN, TR, TW, TZ, UG, VE, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Zyprexa Velotab (AT, BE, BG, CH, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, MT, NL, NO, PL, PT, RU, SE, SK, TR);",
"     </li>",
"     <li>",
"      Zyprexa Zydis (AR, CL, HK, ID, MY, NZ, SG, TH, TW);",
"     </li>",
"     <li>",
"      Zyrepin (KP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F203119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Olanzapine is a second generation thienobenzodiazepine antipsychotic which displays potent antagonism of serotonin 5-HT",
"     <sub>",
"      2A",
"     </sub>",
"     and 5-HT",
"     <sub>",
"      2C",
"     </sub>",
"     , dopamine D",
"     <sub>",
"      1-4",
"     </sub>",
"     , histamine H",
"     <sub>",
"      1",
"     </sub>",
"     and alpha",
"     <sub>",
"      1",
"     </sub>",
"     -adrenergic receptors. Olanzapine shows moderate antagonism of 5-HT",
"     <sub>",
"      3",
"     </sub>",
"     and  muscarinic M",
"     <sub>",
"      1-5",
"     </sub>",
"     receptors, and weak binding to GABA-A, BZD, and beta-adrenergic receptors. Although the precise mechanism of action in schizophrenia and bipolar disorder is not known, the efficacy of olanzapine is thought to be mediated through combined antagonism of dopamine and serotonin type 2 receptor sites.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F203137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Oral: Well absorbed; not affected by food; tablets and orally-disintegrating tablets are bioequivalent",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Short-acting injection: Rapidly absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : Extensive, 1000 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding, plasma: 93% bound to albumin and alpha",
"     <sub>",
"      1",
"     </sub>",
"     -glycoprotein",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Highly metabolized via direct glucuronidation and cytochrome P450 mediated oxidation (CYP1A2, CYP2D6); 40% removed via first pass metabolism",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 21-54 hours; ~1.5 times greater in elderly; Extended-release injection: ~30 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, plasma: Maximum plasma concentrations after I.M. administration are 5 times higher than maximum plasma concentrations produced by an oral dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Extended-release injection: ~7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Short-acting injection: 15-45 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: ~6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (57%, 7% as unchanged drug); feces (30%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Clearance: 40% increase in olanzapine clearance in smokers; 30% decrease in females",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity, &ldquo;Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes,&rdquo;",
"      <i>",
"       Diabetes Care",
"      </i>",
"      , 2004, 27(2):596-601.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/14747245/pubmed\" id=\"14747245\" target=\"_blank\">",
"        14747245",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Baldwin DS and Montgomery SA, &ldquo;First Clinical Experience With Olanzapine (LY 170053): Results of an Open-Label Safety and Dose-Ranging Study in Patients With Schizophrenia,&rdquo;",
"      <i>",
"       Int Clin Psychopharmacol",
"      </i>",
"      , 1995, 10(4):239-44.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/8748045/pubmed\" id=\"8748045\" target=\"_blank\">",
"        8748045",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Carrillo JA, Herraiz AG, Ramos SI, et al, &ldquo;Role of the Smoking-Induced Cytochrome P450 (CYP)1A2 and Polymorphic CYP2D6 in Steady-State Concentration of Olanzapine,&rdquo;",
"      <i>",
"       J Clin Psychopharmacol",
"      </i>",
"      , 2003, 23(2):119-27.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Davis JM, Chen N, and Glick ID, &ldquo;A Meta-analysis of the Efficacy of Second-Generation Antipsychotics,&rdquo;",
"      <i>",
"       Arch Gen Psychiatry",
"      </i>",
"      , 2003, 60(6):553-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/12796218/pubmed\" id=\"12796218\" target=\"_blank\">",
"        12796218",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dixon L, Perkins D, and Calmes C,",
"      <i>",
"       Guideline Watch (September 2009): Practice Guideline for the Treatment of Schizophrenia",
"      </i>",
"      , Arlington, Va: American Psychiatric Association, 2009. Available at file://www.psychiatryonline.com/content.aspx?aid=501001",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Duggal HS, Gates C, and Pathak PC, &ldquo;Olanzapine-Induced Neutropenia: Mechanism and Treatment,&rdquo;",
"      <i>",
"       J Clin Psychopharmacol",
"      </i>",
"      , 2004, 24(2):234-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/15206675/pubmed\" id=\"15206675\" target=\"_blank\">",
"        15206675",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Farwell WR, Stump TE, Wang J, et al, &ldquo;Weight Gain and New Onset Diabetes Associated With Olanzapine and Risperidone,&rdquo;",
"      <i>",
"       J Gen Intern Med",
"      </i>",
"      , 2004, 19(12):1200-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/15610330/pubmed\" id=\"15610330\" target=\"_blank\">",
"        15610330",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gill SS, Bronskill SE, Normand SL, et al, &ldquo;Antipsychotic Drug Use and Mortality in Older Adults With Dementia,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 2007, 146(11):775-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/17548409/pubmed\" id=\"17548409\" target=\"_blank\">",
"        17548409",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Goldberg RJ, &ldquo;Managing Psychosis-Related Behavioral Problems in the Elderly,&rdquo;",
"      <i>",
"       Consult Pharm",
"      </i>",
"      , 1997, 12(Suppl C):4-10.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gorski ED and Willis KC, &ldquo;Report of Three Cases Studied With Olanzapine for Chronic Pain,&rdquo;",
"      <i>",
"       J Pain",
"      </i>",
"      , 2003, 4:166-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/14622714/pubmed\" id=\"14622714\" target=\"_blank\">",
"        14622714",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Khojainova N, Santiago-Palma J, Kornick C, et al, &ldquo;Olanzapine in the Management of Cancer Pain,&rdquo;",
"      <i>",
"       J Pain Symptom Manage",
"      </i>",
"      , 2002, 23(4):346-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/11997204/pubmed\" id=\"11997204\" target=\"_blank\">",
"        11997204",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kiser RS, Cohen HM, Freedenfeld RN, et al, &ldquo;Olanzapine for the Treatment of Fibromyalgia Symptoms,&rdquo;",
"      <i>",
"       J Pain Symptom Manage",
"      </i>",
"      , 2001, 22(2):704-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/11495717/pubmed\" id=\"11495717\" target=\"_blank\">",
"        11495717",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Krishnamoorthy J and King BH, &ldquo;Open-Label Olanzapine Treatment in Five Preadolescent Children,&rdquo;",
"      <i>",
"       J Child Adolesc Psychopharmacol",
"      </i>",
"      , 1998, 8(2):107-13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/9730076/pubmed\" id=\"9730076\" target=\"_blank\">",
"        9730076",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kroon LA, &ldquo;Drug Interactions With Smoking,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2007, 64(18):1917-21.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/17823102/pubmed\" id=\"17823102\" target=\"_blank\">",
"        17823102",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kryzhanovskaya L, Schulz SC, McDougle C, et al, &ldquo;Olanzapine Versus Placebo in Adolescents With Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Trial,&rdquo;",
"      <i>",
"       J Am Acad Child Adolesc Psychiatr",
"      </i>",
"      y, 2009, 48(1):60-70.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/19057413/pubmed\" id=\"19057413\" target=\"_blank\">",
"        19057413",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kumra S, Jacobsen LK, Lenane M et al, &ldquo;Childhood-Onset Schizophrenia: An Open-Label Study of Olanzapine in Adolescents,&rdquo;",
"      <i>",
"       J Am Acad Child Adolesc Psychiatry",
"      </i>",
"      , 1998, 37(4):377-85.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/9549958/pubmed\" id=\"9549958\" target=\"_blank\">",
"        9549958",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lauriello J, Lambert T, Andersen S, et al, &ldquo;An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizphrenia,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 2008, 69(5):790-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/18452346/pubmed\" id=\"18452346\" target=\"_blank\">",
"        18452346",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Moore TA, &ldquo;Schizophrenia Treatment Guidelines in the United States,&rdquo;",
"      <i>",
"       Clin Schizophr Relat Psychoses",
"      </i>",
"      , 2011, 5(1):40-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/21459738/pubmed\" id=\"21459738\" target=\"_blank\">",
"        21459738",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Health and Clinical Excellence (NICE), National Clinical Guideline Centre, &ldquo;Delirium: Diagnosis, Prevention and Management,&rdquo; National Clinical Practice Guideline Number 103, 2010. Available at  file://www.nice.org.uk/CG103",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Health and Clinical Excellence (NICE), National Collaborating Centre for Mental Health, &ldquo;Schizophrenia. Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Updated),&rdquo; National Clinical Practice Guideline Number 82, 2009:1-399. Available at  www.nice.org.uk/cg082",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Navari RM, Einhorn LH, Loehrer PJ, et al, &ldquo;A Phase II Trial of Olanzapine, Dexamethasone, and Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Hoosier Oncology Group Study,&rdquo;",
"      <i>",
"       Support Care Cancer",
"      </i>",
"      , 2007, 15(11):1285-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/17375339/pubmed\" id=\"17375339\" target=\"_blank\">",
"        17375339",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Navari RM, Einhorn LH, Passik SD, et al, &ldquo;A Phase II Trial of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Hoosier Oncology Group Study,&rdquo;",
"      <i>",
"       Support Care Cancer",
"      </i>",
"      , 2005, 13(7):529-34.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/15700131/pubmed\" id=\"15700131\" target=\"_blank\">",
"        15700131",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Passick SD, Navari RM, Jung SH, et al, &ldquo;A Phase I Trial of Olanzapine (Zyprexa) for the Prevention of Delayed Emesis in Cancer Patients: A Hoosier Oncology Group Study,&rdquo;",
"      <i>",
"       Cancer Invest",
"      </i>",
"      , 2004, 22(3):383-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/15493359/pubmed\" id=\"15493359\" target=\"_blank\">",
"        15493359",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rabins PV, Blacker D, Rovner BW, et al, &ldquo;American Psychiatric Association Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias. Second Edition,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 2007, 164(12 Suppl):5-56.  Available at file://psychiatryonline.org/guidelines.aspx",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/18340692/pubmed\" id=\"18340692\" target=\"_blank\">",
"        18340692",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rozen TD, &ldquo;New Treatments in Cluster Headache,&rdquo;",
"      <i>",
"       Curr Neurol Neurosci Rep",
"      </i>",
"      , 2002, 2(2):114-21.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/11898477/pubmed\" id=\"11898477\" target=\"_blank\">",
"        11898477",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schneeweiss S, Setoguchi S, Brookhart A, et al, &ldquo;Risk of Death Associated With the Use of Conventional Versus Atypical Antipsychotic Drugs Among Elderly Patients,&rdquo;",
"      <i>",
"       CMAJ",
"      </i>",
"      , 2007, 176(5): 627-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/17325327/pubmed\" id=\"17325327\" target=\"_blank\">",
"        17325327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schneider LS, Tariot PN, Dagerman KS, et al, &ldquo;Effectiveness of Atypical Antipsychotic Drugs in Patients With Alzheimer's Disease,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2006, 355(15):1525-38.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/17035647/pubmed\" id=\"17035647\" target=\"_blank\">",
"        17035647",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shaw P, Sporn A, Gogtay N et al, &ldquo;Childhood-Onset Schizophrenia: A Double-Blind, Randomized Clozapine-Olanzapine Comparison,&rdquo;",
"      <i>",
"       Arch Gen Psychiatry",
"      </i>",
"      , 2006, 63(7):721-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/16818861/pubmed\" id=\"16818861\" target=\"_blank\">",
"        16818861",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sorsaburu S, Hornbuckle K, Blake D, et al, &ldquo;The First 21 Months of Safety Experience With Postmarketing Use of Olanzapine's Intramuscular Formulation,&rdquo; College of Psychiatric and Neurologic Pharmacists, April, 2006, Baltimore, MD.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Soutullo CA, Sorter MT, Foster KD, et al, &ldquo;Olanzapine in the Treatment of Adolescent Acute Mania: A Report of Seven Cases,&rdquo;",
"      <i>",
"       J Affect Disord",
"      </i>",
"      , 1999, 53(3):279-83.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/10404715/pubmed\" id=\"10404715\" target=\"_blank\">",
"        10404715",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sultzer DL, Davis SM, Tariot PN, et al, &ldquo;Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer&rsquo;s Disease: Phase 1 Outcomes from the CATIE-AD Effectiveness Trial,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 2008, 165(7):844-54.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/18519523/pubmed\" id=\"18519523\" target=\"_blank\">",
"        18519523",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Suppes T, Dennehy EB, Hirschfeld RMA, et al, &ldquo;The Texas Implementation of Medication Algorithms: Update to the Algorithms for the Treatment of Bipolar I Disorder,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 2005, 66(7):870-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/16013903/pubmed\" id=\"16013903\" target=\"_blank\">",
"        16013903",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Thangadurai P, Jyothi KS, Gopalakrishman R, et al, &ldquo;Reversible Neutropenia With Olanzapine Following Clozapine-Induced Neutropenia,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 2006, 163(7):1298.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/16816247/pubmed\" id=\"16816247\" target=\"_blank\">",
"        16816247",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Thinn SS, Liew E, May AL, et al, &ldquo;Reversible Delayed Onset Olanzapine-Associated Leukopenia and Neutropenia in a Clozapine-Naive Patient on Concomitant Depot Antipsychotic,&rdquo;",
"      <i>",
"       J Clin Psychopharmacol",
"      </i>",
"      , 2007, 27(4):394-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/36/37449/abstract-text/17632225/pubmed\" id=\"17632225\" target=\"_blank\">",
"        17632225",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9716 Version 53.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.146-E8BDD971E0-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_36_37449=[""].join("\n");
var outline_f36_36_37449=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5709177\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203156\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203157\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203198\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203161\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203180\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203162\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203163\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203164\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203131\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203116\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11238295\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874938\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203135\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203134\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203194\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203206\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203196\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203138\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203120\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203191\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203125\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203153\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203127\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2839122\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203169\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2839124\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203141\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203140\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203129\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203142\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203119\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203137\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9716\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9716|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?28/16/28934?source=related_link\">",
"      Olanzapine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/24/34185?source=related_link\">",
"      Olanzapine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_36_37450="Cutaneous sarcoidosis - histopathology";
var content_f36_36_37450=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F80383%7EDERM%2F54204&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F80383%7EDERM%2F54204&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cutaneous sarcoidosis - histopathology",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This histologic specimen from a nodular lesion demonstrates a granulomatous infiltrate throughout the dermis. Circumscribed \"naked,\" epithelioid granulomas are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Shane A Meehan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cutaneous sarcoidosis - histopathology",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Large aggregates of histiocytes forming tight, well-demarcated granulomas are present in the dermis. The granulomas lack any signs of caseating necrosis and are surrounded by a small number of lymphocytes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Shane A Meehan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_36_37450=[""].join("\n");
var outline_f36_36_37450=null;
var title_f36_36_37451="Lacunar syndromes";
var content_f36_36_37451=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F67341&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F67341&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classical lacunar syndromes",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Lacunar syndrome",
"       </td>",
"       <td class=\"subtitle1\">",
"        Location",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical findings",
"       </td>",
"       <td class=\"subtitle1\">",
"        Positive predictive value",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pure motor hemiparesis",
"       </td>",
"       <td>",
"        Internal capsule, corona radiata, basal pons, medial medulla",
"       </td>",
"       <td>",
"        Unilateral paralysis of face, arm and leg, no sensory signs, dysarthria and dysphagia may be present",
"       </td>",
"       <td>",
"        52-85 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pure sensory syndrome",
"       </td>",
"       <td>",
"        Thalamus, pontine tegmentum, corona radiata",
"       </td>",
"       <td>",
"        Unilateral numbness of face, arm and leg without motor deficit",
"       </td>",
"       <td>",
"        95-100 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ataxic hemiparesis",
"       </td>",
"       <td>",
"        Internal capsule-corona radiata, basal pons, thalamus",
"       </td>",
"       <td>",
"        Unilateral weakness and limb ataxia",
"       </td>",
"       <td>",
"        59-95 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sensorimotor syndrome",
"       </td>",
"       <td>",
"        Thalamocapsular, maybe basal pons or lateral medulla",
"       </td>",
"       <td>",
"        Hemiparesis or hemiplegia of face, arm and leg with ipsilateral sensory impairment",
"       </td>",
"       <td>",
"        51-87 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dysarthria-clumsy hand syndrome",
"       </td>",
"       <td>",
"        Basal pons, internal capsule- corona radiata",
"       </td>",
"       <td>",
"        Unilateral facial weakness, dysarthria and dysphagia, with mild hand weakness and clumsiness",
"       </td>",
"       <td>",
"        About 96 percent",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_36_37451=[""].join("\n");
var outline_f36_36_37451=null;
var title_f36_36_37452="Monitoring in diabetes mellitus";
var content_f36_36_37452=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F63002&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F63002&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Monitoring in patients with diabetes mellitus",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Intervention",
"       </td>",
"       <td class=\"subtitle1\">",
"        Frequency",
"       </td>",
"       <td class=\"subtitle1\">",
"        Notes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        History and physical examination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Smoking cessation counseling",
"       </td>",
"       <td>",
"        Every visit",
"       </td>",
"       <td>",
"        For smokers only",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Blood pressure",
"       </td>",
"       <td>",
"        Every visit",
"       </td>",
"       <td>",
"        Goal &lt;140/80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dilated eye examination",
"       </td>",
"       <td>",
"        Annually*",
"       </td>",
"       <td>",
"        Begin at onset of type 2 diabetes, three to five years after onset of type 1 diabetes. Examine more than annually if significant retinopathy.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Foot examination",
"       </td>",
"       <td>",
"        Annually",
"       </td>",
"       <td>",
"        Every visit if peripheral vascular disease or neuropathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Laboratory studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fasting serum lipid profile",
"       </td>",
"       <td>",
"        Annually",
"       </td>",
"       <td>",
"        May obtain every two years if profile is low risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        A1C",
"       </td>",
"       <td>",
"        Every three to six months",
"       </td>",
"       <td>",
"        Goal &lt;7 percent (may be lower or higher in selected patients)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Urinary albumin-to-creatinine ratio",
"       </td>",
"       <td>",
"        Annually",
"       </td>",
"       <td>",
"        Begin three to five years after onset of type 1 diabetes; protein excretion and serum creatinine should also be monitored if persistent albuminuria is present",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Serum creatinine",
"       </td>",
"       <td>",
"        Initially, as indicated",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Vaccinations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pneumococcus",
"       </td>",
"       <td>",
"        One time",
"       </td>",
"       <td>",
"        Patients over age 65 need a second dose if vaccine was received &ge;5 years previously and age was &lt;65 at time of vaccination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Influenza",
"       </td>",
"       <td>",
"        Annually",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hepatitis B",
"       </td>",
"       <td>",
"        Three dose series",
"       </td>",
"       <td>",
"        Administer to unvaccinated adults who are ages 19 to 59 years. For older patients, administer based upon risk of acquiring hepatitis B and likelihood of an adequate immune response to vaccination.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Education, self management review",
"       </td>",
"       <td>",
"        Annually",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Less frequent screening (every two to three years) may be appropriate for some patients.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_36_37452=[""].join("\n");
var outline_f36_36_37452=null;
var title_f36_36_37453="Contents: Special sites of care and allied health professions";
var content_f36_36_37453=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?34/55/35709\">",
"       Palliative Care",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Special sites of care and allied health professions",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Special sites of care and allied health professions",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Family",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/40/12938\">",
"           Communication in the ICU: Holding a family meeting",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         General",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/9/42138\">",
"           Medical care of the nursing home patient in the United States",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hospice",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/16/32008\">",
"           Hospice: Philosophy of care and appropriate utilization in the United States",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Site of care",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/60/26565\">",
"           Ethics in the intensive care unit: Informed consent",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/22/24934\">",
"           Ethics in the intensive care unit: Responding to requests for futile or potentially inappropriate therapies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/7/32887\">",
"           Ethics in the intensive care unit: Withholding and withdrawing life-support",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/9/44185\">",
"           Health care of homeless persons",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-69F2778236-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f36_36_37453=[""].join("\n");
var outline_f36_36_37453=null;
var title_f36_36_37454="Occlusal cant";
var content_f36_36_37454=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F80119&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F80119&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Occlusal cant due to a mandibular abnormality",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 205px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Occlusal cant is demonstrated by having the child bite down on a tongue depressor to identify any angulation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_36_37454=[""].join("\n");
var outline_f36_36_37454=null;
var title_f36_36_37455="Relative malaria rates";
var content_f36_36_37455=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F67552&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F67552&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 615px\">",
"   <div class=\"ttl\">",
"    Number of imported malaria cases and estimated relative case rates* among US civilians, by country of acquisition - United States, 2006",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 595px; height: 512px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Using estimates of travel volume for US travelers to each country from which cases of malaria were acquired, and the number of cases among US travelers attributable to each country, a case rate was estimated for each country. Data used to estimate country-specific relative case rates were extrapolated from World Tourism Organization estimates of annual numbers of US travelers to specific countries (6). Relative case rates were determined by dividing the individual country-specific case rate by the median individual country-specific case rate. The number of cases of malaria among US civilian travelers attributable to each country is displayed next to the country name in parentheses. Note that certain risk estimates are based on small numbers of cases.",
"    </div>",
"    <div class=\"reference\">",
"     Mali, S, Steele, S, Slutsker, L, Arguin, PM. Malaria surveillance - United States, 2006. MMWR Surveill Summ 2008; 57:24.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_36_37455=[""].join("\n");
var outline_f36_36_37455=null;
